Abstracts of 2008 Clinical Meetings Poster Presentations
More than 300 study abstracts were presented on posters, highlighting critical issues such as acute kidney injury, ICU medicine, transplantation, hemodialysis, diabetes, and hypertension, among many other topics. Explore the list below for more information.
Abstract Topic List
- EXCEPTIONS TO THE PARADIGMS OF FRACTIONAL EXCRETION OF UREA IN THE DIFFERENTIAL DIAGNOSIS OF ACUTE RENAL FAILURE.
Arun Amatya, Mauro Braun, Rute Paixao, Beth Fromkin, Diane Sandy
Cleveland Clinic Florida (CCF),Weston, FL, USA.
- IRREVERSIBLE ACUTE RENAL FAILURE? NOT SO FAST
Hatem Amer, Nelson Leung; Mayo Clinic, Rochester, MN, USA
- INTRACAVITARY AMINOGLYCOSIDES AND ACUTE TUBULAR NECROSIS
Doreen Bett, Ashfaq Balla, Alan Schned, Clay Block.; Dartmouth Hitchcock Medical Center, Lebanon, NH. USA
- OUTCOME-PREDICTABILITY OF THE ETIOLOGICAL AKI CATEGORIZATION AND THE NOVEL RIFLE CLASSIFICATION
Alan Brijbassie1,2, Sajid George1,2, Smriti Sharma1,2, Jude Ojie1,2, Kamyar Kalantar-Zadeh3, Csaba Kovesdy1. 1VA Medical Center, Salem, VA, 2Carilion Clinic Roanoke VA and Harbor UCLA, 3Torrence, CA.
- ACUTE INTERSTITIAL NEPHRITIS AND PPIs: CASE REPORT AND REVIEW OF LITERATURE
Micah R. Chan, Alexander S. Yevzlin, Weixong Zhong, Paul S. Kellerman, University of Wisconsin Hospitals, Madison, WI
- CALCIPHYLAXIS RESPONSIVE TO LANTHANUM CARBONATE (FOSRENOL) THERAPY
Micah R. Chan, Alexander S. Yevzlin, Molly Hinshaw, Jonathan B. Jaffery, University of Wisconsin and Affiliated Hospitals, Madison, WI
- MINIMAL CHANGE DISEASE (MCD) PRESENTING AS ACUTE KIDNEY INJURY AND NEPHROTIC-RANGE PROTEINURIA WITHOUT EDEMA
Arvind Datla, Fabio Aglieco, M. Atiq Dada, Wilner Samson.University of Connecticut
- OUTCOMES OF ACUTE KIDNEY INJURY ASSOCIATED WITH INHIBITORS OF RENIN-ANGIOTENSIN SYSTEM
Sajid Melvin George, Alan Brijbassie, Smriti Sharma, Jude Ojie, Kamyar Kalantar-Zadeh, Csaba Kovesdy. VA Medical Center, Salem, VA Carilion Clinic, Roanoke, VA and Harbor UCLA, Torrance, CA
- ACUTE INTERSTITIAL NEPHRITIS (AIN) SECONDARY TO VANCOMYCIN. CASE REPORT AND LITERATURE REVIEW OF VANCOMYCIN NEPHROTOXICITY IN MODERN ERA
Manish Gera1, R. Jeevan1, S. Dhar1, C.L. Phillips2. Internal Medicine Nephrology Inc. Terre Haute, IN1. I. U. Pathology, Indianapolis, IN2
- SURVIVAL OF ELDERLY PATIENTS WITH ACUTE KIDNEY INJURY REQUIRING CONTINUOUS RENAL REPLACEMENT THERAPY
Haque, Ammar; Dall, Aaron; Hussain, Syed; Regner, Kevin. Medical College of Wisconsin, Milwaukee, WI, USA
- PREVENTION OF CONTRAST NEPHROPATHY: ARE PRACTICE PATTERNS CONGRUENT WITH CURRENT RECOMMENDATIONS?
Praveen Kandula±, Nishith Singh±, Sagar U Nigwekar*,
± Southern Illinois University, Springfield, IL; * Rochester General Hospital, Rochester, NY
- ACUTE AND REVERSIBLE VANCOMYCIN NEPHROTOXICITY: A CASE SERIES
Marco Ladino, Manju Alex, and Ivonne Hernandez Schulman; Division of Nephrology and Hypertension, Veterans Affairs Medical Center and University of Miami Miller School of Medicine, Miami, FL, USA
- PILOT STUDY OF BRAIN NATRIURETIC PEPTIDE (BNP) FOR THE PREVENTION OF RADIOCONTRAST INDUCED NEPHROPATHY (RCIN) AFTER CARDIAC CATHETERIZATION
Rakesh Lattupalli, Desikan Kamalakannan, Nancy Mesiha, Susan Steigerwalt, Robert Provenzano, Howard Rosman, Quresh Khairullah; Division of Nephrology, St John Hospital and Medical center, Detroit, MI
- ORAL SODIUM PHOSPHATE LAXATIVE ASSOCIATED ACUTE RENAL FAILURE
Kelly Liang, Iasmina Craici, Kianoush Kashani, Hatem Amer, and John Dillon
Mayo Clinic, Rochester, MN, USA
- BILATERAL ADRENAL HEMORRHAGE (BAH) – A REVERSIBLE CAUSE OF ACITE RENAL FAILURE (ARF)
Mand, Raminder., Desai, Chetainya., Chaudhari, Ashok.
- INCIDENCE, ETIOLOGY, AND OUTCOMES OF HOSPITAL ACQUIRED
ACUTE RENAL FAILURE (HAARF) IN ELDERLY
Subrahmanyam Nasika, Saurabh Kumar Goel, Robert Krinsky, Kalyana Janga, Suneeta Gadde, Sheldon Greenberg, Winston Lee. Maimonides Medical Center, Brooklyn, New York
- THYROXINE FOR ACUTE KIDNEY INJURY IN HUMANS: A SYSTEMATIC REVIEW
Sagar U Nigwekar*, Sankar D Navaneethan±, Giovanni FM Strippoli¶; *Rochester General Hospital, Rochester, NY, USA, ±University of Rochester, Rochester, NY, USA, ¶Cochrane Renal Group, Australia.
- PROPOSED PATHOPHYSIOLOGY OF ACUTE KIDNET INJURY FOLLOWING RETROGRADE PYELOGRAPHY
Vishwas Patel, Hanan Fahmy, University of Illinois, Urbana, IL
- GRANULOMATOUS INTERSTITIAL NEPHRITIS SECONDARY TO CARBAMAZEPINE CAUSING ACUTE RENAL FAILURE
Prashanth Podaralla1, Nagaraju Sarabu2, Marcos Rothstein1, 1 Barnes Jewish Hospital, Washington University, St. Louis, MO. 2 St. Luke’s Hospital, Chesterfield, MO
- CLINICAL UTILITY OF RENAL ULTRASOUND IN ACUTE KIDNEY INJURY
Amber S. Podoll, Kevin W. Finkel; University of Texas Health Science Center, Houston Texas
- CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME DUE TO INADEQUATE ANTICOAGULATION LEADING TO END STAGE RENAL DISEASE
Christopher R. Provenzano, MD, Anjali Acharya, MD, Jacobi Medical Center, Albert Einstein College, Bronx, New York.
- A RETROSPECTIVE STUDY ON THE MORTALITY OF BONE MARROW TRANSPLANT RECIPIENTS WITH SEVERE ACUTE KIDNEY INJURY
Archana Rao, Andrew Fenves, Joseph Fay, Baylor University Medical Center,
Department of Oncology and Division of Nephrology, Dallas, TX, USA.
- DEFERIPRONE AMELIORATES CISPLATIN INJURY TO RENAL TUBULAR EPITHELIAL CELLS
Sudhir V. Shah, Xiaoying Wang, Eugene O. Apostolov, Alexei G. Basnakian. University of Arkansas for Medical Sciences & Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA
- A RARE CASE OF LUNESTA (ESZOPICLONE) INDUCED ACUTE INTERSTITIAL NEPHRITIS
Alok Silodia, Robert N.Pursell, Richard W. Snyder, Department of Nephrology, St. Lukes Hospital and Health Network, Bethlehem, PA
- ACUTE RENAL FAILURE CAUSED BY SPONTANEOUS ACUTE TUMOR LYSIS SYNDROME FROM UTERINE SARCOMA.
Praveen R. Yalamanchili, Sumanth Daram, Ashok Kondur. Peoria, AZ; USA.
- EMPHYSEMATOUS PYELONEPHRITIS NOT IDENTIFIED ON ROUTINE RENAL ULTRASOUND
Sarika Kadam1, Satyarth Kulshrestha2, Edwin Anand3 Leon Kurtz4 Louis Eichel5, John Kevin Hix6; 12346Dept of Medicine, 5 Dept of Urology at Rochester General Hospital, Rochester, NY
- EFFECT OF A BEHAVIORAL MODIFICATION PROGRAM ON PROTEINURIA IN THOSE WITH TYPE 2 DIABETES
Matthew Novak, University of Pittsburgh School of Medicine Pittsburgh, PA; Beth Piraino, University of Pittsburgh School of Medicine Pittsburgh, PA; Dianxu Ren, University of Pittsburgh School of Nursing, Pittsburgh, PA; Mary Ann Sevick, University of Pittsburgh School of Medicine Pittsburgh, PA.
- PIOGLITAZONE REDUCES RENAL FIBROSIS IN A RAT MODEL OF TYPE 2 DIABETES
1Toblli Jorge; 2Ferrini Monica G, 1Cao Gabriel, 2Vernet Dolores, 1Angerosa Margarita 2Gonzalez Cadavid Nestor F. 1Lab. of Experimental Medicine. Hospital Alemán. Buenos Aires, Argentina. 2LABioMed at Harbor-UCLA Medical Center. Torrance, CA, USA.
- HYPOKALEMIA ASSOCIATED WITH CARCINOID TUMOR OF THE THYMUS AND COMPLICATED BY BILATERAL ADRENAL HEMORRHAGE
Ammar Almehmi*, shahzad Shafique, Amer Malas, Samar Sankari; *Kansas University Medical Center, Kansas city, Kansas, USA
- HETEROLOGOUS DOWNREGULATION OF VASOPRESSIN TYPE 2 RECEPTOR IS INDUCED BY TRANSFERRIN
Bouley, R., Nunes, P. and Brown, D.; Program in Membrane Biology, Nephrology Division, Massachusetts General Hospital, Boston, MA
- FACTITIOUS HYPERPHOSPHATEMIA DUE TO SAMPLE CONTAMINATION WITH HEPARIN IN AN ARTERIAL LINE
Ziad El-Zoghby1; Kevin Regner1; Mark Keegan2; Edward Casey1; Divisions of Nephrology1 and Critical Care2, Mayo Clinic, Rochester, MN
- ACQUIRED FANCONI SYNDROME AND SEVERE HYPOPHOSPHATEMIA AFTER EXPOSURE TO BEE VENOM
Gibbons R, Salahuddin S
- REFRACTORY HYPOKALEMIA: A CASE OF TOPIRAMATE-INDUCED RENAL TUBULAR ACIDOSIS (RTA)
Kelly Liang, Stephen Erickson, John Dillon, Suzanne Norby; Mayo Clinic, Rochester, MN, USA
- FAMILIAL HYPOMAGNESEMIA WITH SECONDARY HYPOCALCEMIA CAUSED BY TRPM6 GENE MUTATIONS
Ravi K. Mallavarapu, Stanley T. Peskoe, Mercer University School of Medicine, Macon, GA, USA
- RENAL TUBULAR ACIDOSIS WITH FANCONI SYNDROME ASSOCIATED WITH TENOFOVIR.
Brindusa Mocanu, Brant Holt, University of Tennessee at Chattanooga, TN, USA
- METFORMIN ASSOCIATED LACTIC ACIDOSIS: THE MARSHFIELD CLINIC EXPERIENCE
Falgun Modhia, Douglas P. Duffy, Michael D. Hammeke and Narayana S. Murali, Marshfield Clinic, Marshfield, Wisconsin, USA.
- METFORMIN ASSOCIATED LACTIC ACIDOSIS (MALA) PRESENTING AS MYOCARDIAL INFARCTION IN A CHRONIC DIALYSIS PATIENT
Chris Provenzano, MD, Anjali Acharya, MD, Jacobi Medical Center, Albert Einstein Collage, Bronx, NY, USA
- HEMODIALYSIS FOR METFORMIN-ASSOCIATED LACTIC ACIDOSIS
Erdal Sarac, Hui Zhang, Thomas Detesco, and Hilmer Negrete; Department of Medicine, St. Elizabeth Hospital, Youngstown, Ohio, and Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, USA.
- SERUM PHOSPHATE LEVELS AND MORTALITY IN PATIENTS WITH NORMAL RENAL FUNCTION ATTENDING INNER-CITY OUTPATIENT CLINICS
Matthew Abramowitz, William Southern, Irwin Lotwin, Maria Coco, Thomas Hostetter, Michal L. Melamed; Albert Einstein College of Medicine, Bronx, NY
- A SYSTEMATIC REVIEW AND META-ANALYSIS: THE USE OF PLASMA EXCHANGE FOR TREATMENT OF ACUTE RENAL FAILURE IN MULTIPLE MYELOMA
Ashok Ammula1, Jonathan Sosnov2, Adam Segal1, Joline Chen1; 1. Renal Section, Department of Medicine, Boston University, Boston, MA; 2. Division of Nephrology and Hypertension, Miller School of Medicine, University of Miami, Miami, FL
- PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD) IN THE HOSPITAL SETTING
Arie Barlev1, Sidney Thornton2, John Holmen2, Anthony G. Bower1. 1Amgen Inc., Thousand Oaks, CA, USA, 2Intermountain Healthcare, Salt Lake City, UT, USA
- EFFECT OF VITAMIN D3 SUPPLEMENTATION ON BONE MINERAL DENSITY IN CHRONIC KIDNEY DISEASE
Cortney Bosworth, Laura Kooienga, Jessica Kendrick, Gerard Smits, Michel Chonchol. University of Colorado Health Sciences Center, Denver, CO, USA
- ADJUSTMENT FOR EXPOSURE HISTORY AND IMPORTANT CONFOUNDERS MARKEDLY ATTENUATES ELEVATED MORTALITY RISK ASSOCIATED WITH EPOETIN ALFA (EPO) DOSE
Bradbury BD1, Do T1, Rothman KJ2, Critchlow CW1, Collins A3, Brookhart MA4, Krishnan M1, Acquavella JF1
1Amgen Inc., Thousand Oaks, CA; 2Research Triangle Institute, Research Triangle, NC; 3Chronic Disease Research Group, Minneapolis, MN; 4Div. of Pharmacoepidemiology, Harvard University, Boston, MA
- INPATIENT USE OF ERYTHROPOIESIS STIMULATING AGENTS (ESA) AMONG COMMERCIALLY-INSURED DIALYSIS PATIENTS
1Donald Brophy, 2Carolyn Harley, 2Benjamin Chastek, 3Gregory Daniel, 3Brian McNeeley, 4Matthew Gitlin, 4Tracy J Mayne. 1Virginia Commonwealth Univ, Richmond, VA; 2i3 Innovus, Eden Prairie, MN; 3HealthCore, Inc, Wilmington, DE, 4Amgen Inc., Thousand Oaks, CA
- PARTICIPANT FOLLOW-UP IN THE KIDNEY EARLY EVALUATION PROGRAM (KEEP) AFTER INITIAL DETECTION
Allan J. Collins1, Suying Li1, Shu-Cheng Chen1. 1Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota
- SCREENING PRACTICES FOR CHRONIC KIDNEY DISEASE(CKD)IN SOUTH CAROLINA
Keidre J Corbett, B.Egan, J.Chen, Medical University of South Carolina, Charleston, SC, USA
- ASSOCIATION BETWEEN SINUS HISTIOCYTOSIS AND RENAL CELL CARCINOMA: A CASE SERIES
Ziad El-Zoghby; Nelson Leung; Department of Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN
- IDENTIFICATION OF PATIENTS WITH CKD USING MEDICARE DATA: INPATIENT VS. OUTPATIENT CLAIMS
David T. Gilbertson1, Tricia Roberts1, Thomas Arneson1, Stephan Dunning1, Allan Collins1, Brian Bradbury2. 1 Chronic Disease Research Group, Minneapolis, MN, USA. 2 Amgen, Thousand Oaks, CA, USA
- THE IMPACT ON THE US BLOOD SUPPLY OF BLOOD TRANSFUSIONS IN DIALYSIS
Gitlin M, Hollenbeak C, Mayne TJ, Amgen Inc., Thousand Oaks, CA; Pennsylvania State University College of Medicine, Hershey, PA
- INCREASED USE OF SPECIFIC CKD STAGING CODES FROM 2004 TO 2006
Daniel Halevy, Iver Juster, Yunfeng Li, Madhavi Vemireddy and Greg Steinberg
- OUTCOMES OF CULTURAL COMPETENCY BASED PATIENT EMPOWERMENT DURING IMPLEMENTATION OF CKD CLINIC MODEL OF DIABETES MANAGEMENT
Vipin Jain, J. Sevilla, T. Zollinger, Indianapolis, Indiana, USA
- A REVIEW OF THE EFFECT OF EPOETIN ALFA ON EXERCISE TOLERANCE AND PHYSICAL FUNCTIONING
Jansen JP1, Evans CE1, Guyot P1, Mayne TJ2; 1Mapi Values, 2Amgen Inc.
- THE KIDNEY EARLY EVALUATION PROGRAM: PROGRAM DESIGN AND DEMOGRAPHIC CHARACTERISTICS
Claudine Jurkovitz1, Yang Qiu2, Changchun Wang2, Wendy Brown3
1Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE; 2Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, 3Jesse Brown Veterans Administration Medical Center, Chicago, IL, United States
- 25-HYDROXYVITAMIN D AND INFLAMMATION AND ITS ASSOCIATION WITH HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE
Jessica Kendrick, Gerard Smits, Michel Chonchol. University of Colorado Health Sciences Center, Denver, CO, USA
- 25-HYDROXYVITAMIN D, CARDIOVASCULAR DISEASE AND KIDNEY FUNCTION IN THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY
Jessica Kendrick, Gerard Smits, Michel Chonchol. University of Colorado Health Sciences Center, Denver, CO, USA
- USE OF EPOETIN ALFA IN MAINTANING HEMOGLOBIN CONTROL THROUGH A SOFTWARE-BASED MANAGEMENT TOOL IN A COMMUNITY NEPHROLOGY SETTING
Craig Kleinmann1, Kathy Welch2, Brahim K. Bookhart3, Samir H. Mody3, Robert Bailey3, James Jackson4; 1Nephrology Associates, Mobile, Alabama, USA, 2Coastal Clinical Research, Inc., Mobile, Alabama, USA, 3Ortho Biotech Products, L.P., Bridgewater, New Jersey, USA, 4Xcenda, Palm Harbor, FL, USA
- DEPRESSION IN THE CHRONIC KIDNEY DISEASE (CKD) POPULATION AND ITS ASSOCIATION WITH INFLAMMATORY MARKERS
frederick lee, patricia dubbert, kent kirchner, monique moxey, anita basu, geeta gyamlani, nephrology division, g.v (sonny) montgomery veterans affairs medical center, jackson ms; university of mississippi medical center, jackson, ms.
- URIC ACID AND LONG-TERM OUTCOMES IN CHRONIC KIDNEY DISEASE
Magdalena Madero, Mark Sarnak, Tom Greene, Allan Collins, Gerald Beck, Tom Greene, John Kusek, Andrew Levey, Vandana Menon. Tufts-New England Medical Center, Boston, MA, US
- SURVIVAL OF PATIENTS COMMENCING RENAL REPLACEMENT THERAPY AT AGE 70 AND ABOVE
Roshan Mainali, Martha Kitchen, Wendy Baker, James Hartle, Evan Norfolk, Michael Schultz, William DiFilippo, Rajesh Govindasamy and Taher Yahya. Geisinger Medical Center, Danville, PA, USA
- HEALTH ECONOMIC EVALUATION OF PARICALCITOL COMPARED TO NON-SELECTIVE VITAMN D RECEPTOR ACTIVATOR FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE PATIENTS: US PERSPECTIVE
Mark Nuijten1, Dennis L. Andress2, Steven E. Marx2, Raimund Sterz2 (1) Ars Accessus Medica, Erasmus University, Rotterdam, The Netherlands, (2) Abbott, Abbott Park, IL, USA
- A REANALYSIS OF THE CANADIAN ERYTHROPOIETIN STUDY GROUP (CESG) PATIENT-REPORTED OUTCOMES (PRO) TRIAL
Muirhead N, Keown P, Gitlin M, Mayne TJ, Churchill, DN. UWO, CAN. UBC, CAN. Amgen, USA; Amgen, CAN
- INITIAL SCHOOL URINALYSIS SCREENING IN THE REPUBLIC OF PALAU
Satoshi Ogata, Tsuyoshi Kobayashi, Kojiro Koyama, Masahiro Mori, Satoru Matsuki, Yorimitsu Tatsukawa; Department of Internal Medicine, Sanyo Hospital, Hiroshima, Japan
- TRENDS IN CORONARY ARTERY BYPASS GRAFT SURGERY AMONG ESRD PATIENTS
Dipen S Parikh, Madhav Swaminathan, Laura E Archer, Jula K Inrig, Lynda A Szczech, Andrew D Shaw, Uptal D Patel. Duke Univ Med Ctr, Durham, NC, USA
- PREVALENT COMPONENTS OF CARDIOMETABOLIC SYNDROME AND CARDIOVASCULAR DISEASE FROM THE KIDNEY EARLY EVALUATION PROGRAM (KEEP)
BS Pavey1, G Saab1, SI McFarlane2, JR Sowers1, S Chen3, S Li3, J Vaselotti4, A Collins3, K Norris5, P McCullough6, G Bakris7, A Whaley-Connell1. University of Missouri-Columbia School of Medicine1, Columbia, MO; State University of New York-Downstate, Brooklyn, NY2, Chronic Disease Research Group, Minneapolis Medical Research Foundation3, Mount Sinai School of Medicine4, Charles Drew University and David Geffen School of Medicine, University of California Los Angeles, California5, William Beaumont Hospital, Detroit, MI6, University of Chicago School of Medicine, Illinois, Chicago, IL7
- METABOLIC SYNDROME IN U.S. ADULTS INCREASES WITH DECREASED GFR: RESULTS FROM NHANES SURVEYS (2001-2004)
James F. Reed III, Nelson P. Kopyt
- PERIPHERAL ARTERIAL DISEASE IN U.S. ADULTS WITH METABOLIC SYNDROME INCREASES WITH DECREASED GFR: RESULTS FROM NHANES SURVEYS (2001-2004)
James F. Reed III, Nelson P. Kopyt
- EFFECT OF TREATMENT OF VITAMIN D DEFICENCY/ INSUFFIENCY (VDDI) ON MINERAL METABOLISM IN NON-DIALYZED PATIENTS WITH CKD (ND-CKD)
Sudheer Sankar, Abdul Abdellatif, Zakaria Hamdan, John Gelfond, Fang-Ying Lin and Wajeh Qunibi. Dept of Medicine. University of Texas Health Science Center. San Antonio, TX
- PREVALENCE AND PROGRESSION OF CHRONIC KIDNEY DISEASE AMONG DIFFERENT RACES
Samir N. Shah, Bernadette Thomas, Jamie Hirsch, Thomas Hostetter, Michal L. Melamed; Albert Einstein College of Medicine, Bronx, NY
- BIAS INTRODUCED BY HOSPITALIZATION
EVENTS WHEN ANALYZING EPO DOSING PATTERNS
Craig Solid1, Dave Gilbertson1, Stephan Dunning1, Brian Bradburry2, Tom Arneson1, Allan Collins1; 1Chronic Disease Research Group, Minneapolis, MN, USA; 2Amgen, their city, CA, USA
- PERCEPTIONS REGARDING OPTIMAL FREQUENCY OF DIALYSIS-BASED PHYSICIAN (MD) VISITS IN ESRD: RESULTS OF A NATIONAL PROVIDER SURVEY
Amar Desai; Roger Bolus; Allen Nissenson; Sally Bolus; Matt Solomon; Osman Khawar; Jennifer Talley; Brennan Spiegel West L.A. VA;UCLA.
- PERCEPTIONS REGARDING OPTIMAL FREQUENCY OF DIALYSIS MULTIDISCIPLINARY CARE CONFERENCES: RESULTS OF A NATIONAL PROVIDER SURVEY
Amar Desai; Roger Bolus; Allen Nissenson; Sally Bolus; Matt Solomon; Osman Khawar; Jennifer Talley; Brennan Spiegel West L.A. VA;UCLA
- NO CONSISTENT VITAMIN D EFFECT ON CARDIOVASCULAR MORTALITY ACROSS DIALYSIS VINTAGE GROUPS
WL. St. Peter, S Li, J Liu, DT. Gilbertson, TJ. Arneson, AJ. Collins, Chronic Disease Research Group, Minneapolis, MN USA
- THE EFFECT OF ANEMIA IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE: HOSPITAL COSTS AND LENGTH OF STAY
Sulsky S1, Luippold RS1, Bookhart BK2, Corral M2, Piech CT2.
1) ENVIRON Int’l Corp, Amherst, MA, U.S.A.; 2) Ortho Biotech Products, Bridgewater, NJ, U.S.A.
- COMMUNITY PARTNERED APPROACHES TO ENHANCE CHRONIC KIDNEY DISEASE PREVENTION AND EARLY INTERVENTION
Roberto B. Vargas1, 2, Loretta Jones3, Chrystene Terry4, Joel Kopple1, 5, Keith C. Norris1, 5 and the Building Bridges to Optimum Health World Kidney Day Los Angeles 2007 Pre-Conference Collaborative; Department of Internal Medicine, the David Geffen School of Medicine, UCLA1, RAND Corporation2, Healthy African-American Families, Los Angeles, CA3, Charles Drew University of Medicine and Science4, and the Division of Nephrology, Harbor/UCLA Hospital5
- TRENDS IN MINERAL METABOLISM IN THE KIDNEY EARLY EVALUATION PROGRAM (KEEP)
Joseph A. Vassalotti, MD1,2, Jaime Uribarri, MD2, Shu-Cheng Chen, MS3, Suying Li, PhD3, Changchun Wang, MS3, Allan J. Collins, MD, FACP3,4, Mona S. Calvo, PhD5, Adam Whaley-Connell, MD6, Keith C. Norris, MD7,8, Peter A. McCullough, MD, MPH9, Dennis L. Andress, MD10 on behalf of the KEEP Investigators. 1-10Attributions for the authors will be provided if accepted as a poster.
- VARIATIONS IN SMALL DIALYSIS ORGANIZATIONS (SDOs) HAVE IMPLICATIONS FOR BUNDLING
Whalen J, Bhat JG, Agarwal J, Boleyn DR, Gehling J, Hollenbeak C, de Lissovoy G. Tri-State Dialysis, WI; Atlantic Dialysis Management, NY; Pennsylvania State Univ. College of Medicine, PA; United BioSource Corp, MD
- CHRONIC KIDNEY DISEASE IN THE US: KEEP AND NHANES
A Whaley-Connell1, JR Sowers1, SI McFarlane2, LA Stevens3, M Shlipak4, K Norris5,6, SC Chen7, Y Qiu7, C Wang7, JA Vassalotti8, AJ Collins7 on Behalf of the KEEP Investigators.
- DIABETES MELLITUS IN CKD: KEEP AND NHANES 1999-2004.
A Whaley-Connell1 JR Sowers1 SI McFarlane2 K Norris3,4 SC Chen5 S Li5 Y Qiu5 C Wang5 LA Stevens6 JAVassalotti7,8 A Collins5 and KEEP Investigators. 1University of Missouri-Columbia School of Medicine, Columbia, Missouri, 2SUNY Downstate, Brooklyn, New York, 3Charles R. Drew University of Medicine and Science, 4David Geffen School of Medicine, University of California Los Angeles, California, 5Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, 6Tufts-New England Medical Center, Boston, Massachusetts, 7National Kidney Foundation, New York, New York, 8Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York
- A NOVEL APPROACH TO CONTROLLING MARKERS OF METABOLIC SYNDROME IN END-STAGE RENAL DISEASE PATIENTS
Ronald L. Wilson, Central Texas Nephrology Associates Waco, Texas, USA, Brian Shelmadine, MS, Baylor University, Waco, Texas, USA, Rodney G. Bowden, Baylor University, Waco, Texas, USA., Mindy Gentile, NutrePletion Resources, Bensalem, PA, Daniel P. Beavers, Baylor University, Waco, Texas
- UNUSUAL PRESENTATION OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH ACUTE RENAL FAILURE
Manju Alex, Marco Ladino, and Ivonne Hernandez Schulman
Division of Nephrology and Hypertension, Veterans Affairs Medical Center and University of Miami Miller School of Medicine, Miami, FL, USA
- TRANSCRIPTIONAL ANALYSIS OF IgA NEPHROPAHY BIOPSIES: TOWARDS A MOLECULAR CLASSIFICATION
Celine C Berthier1, Vidooshi G Maru1, Viji Nair1, Felix Eichinger1, Anna Henger1, Anissa Boucherot1,2, Maria P. Rastaldi3, Hermann-Josef Groene4, Clemens D. Cohen2, Matthias Kretzler1 and the European Renal cDNA Bank (ERCB) consortium
1Internal Medicine, University of Michigan-Ann Arbor-MI; 2University of Zurich-Switzerland; 3Immunopathology-Milan-Italy; 4German Cancer Research Center-Heidelberg-Germany.
- SUCCESSFUL TREATMENT OF MULTI-DRUG RESISTANT FSGS WITH BASILIXIMAB
Glenn H. Bock, Barbara Leauber, Kimberly Capp; Dep’t of Pediatrics; Geisinger Medical Canter; Danville, PA
- COLLAPSING FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) WITH SPONTANEOUS RECOVERY OF RENAL FUNCTION
Mathai M Chalunkal,, Richard W. Snyder, Robert N.Pursell. Department of Nephrology, St. Lukes Hospital and Health Network, Bethlehem, PA
- HO-1 OVEREXPRESSION REDUCES PROTEINURIA IN EARLY GLOMERULAR IMMUNE INJURY.
Alan Chu, Pu Duann, Elias Lianos, Robert Wood Johnson University Hospital, New Brunswick, NJ
- RITUXIMAB: A NOVEL TREATMENT OPTION FOR FIBRILLARY GLOMERULONEPHRITIS?
Michael Collins1, Sankar D Navaneethan2, James Sloand2, Brad Rovin1; 1Ohio State University, Columbus, OH, USA & 2University of Rochester Medical Center, Rochester, NY, USA
- EMERGING THERAPIES IN MEMBRANOUS NEPHROPATHY - A CASE SERIES
Abhishek Deshmukh, Jack Kleinman, Samuel Blumenthal, Syed Hussain
Clement J. Zablocki VAMC Milwaukee, Wisconsin
- REVERSIBLE CAUSE OF ACUTE KIDNEY INJURY IN A PATIENT WITH RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
Sajid Melvin George, Son Nguyen, Jon Sweet, Csaba Kovesdy. VA Medical Center, Salem, VA & Carilion Clinic, Roanoke, VA
- AN UNUSUAL CASE OF NON-CRESCENTRIC IGA NEPHROPATHY (IgAN) WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA). A CASE REPORT AND REVIEW OF LITERATURE
Manish Gera1, R. Jeevan1, S. Dhar1, C.L. Phillips2. Int. Med. Nephrology Inc. Terre Haute, IN1. I. U. Pathology, Indianapolis, IN2
- VENOUS THROMBOEMBOLISM AS THE INITIAL PRESENTATION OF PRIMARY RENAL AMYLOIDOSIS
Mythili Ghanta, Sriranga L Bonam , Rajan Kapoor, Anjali Acharya-Jacobi Medical Center, Bronx, New York, US
- RENAL MANIFESTATIONS OF POEMS SYNDROME
Gaurav Jain, Ivan Maya, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL.
- A CASE OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) CAUSED BY HEPATITIS A VIRUS
Raghuveer Kura.M.D, Pritika Shrivastava.M.D, Muriel Fitzsimons.M.D, Navin Verma.M.D. Penn State Milton S. Hershey Medical Center
- PEGFILGASTIM INDUCES A CRESCENTIC GLOMERULONEPHRITIS
Jorge Lamarche, Alfredo Peguero, Craig Courville, AnaVelez, and Ala’a Farahat James A. Haley Veterans Hospital and the University of South Florida Tampa, FL USA
- STEROID RESISTANT MINIMAL CHANGE DISEASE ASSOCIATED WITH THYMOMA: A CASE REPORT
Rakesh Lattupalli, Quresh Khairullah, Keith Bellovich, Joel Topf. Division of Nephrology, St John Hospital and Medical center, Detroit, Mi, USA
- PROLYL-3 HYDROXYLASE EXPRESSION IN THE MOUSE KIDNEY AND DEVELOPING EMBRYO
Jennifer Lennington1, Roy Morello1, Ming-Ming Jiang1, Dustin Baldridge1, Terry Bertin1 and Brendan Lee1,2 1Department of Molecular and Human Genetics, Baylor College of Medicine, 2Howard Hughes Medical Institute
- PAUCIIMUNE CRESCENTIC GLOMERULONEPHRITIS IN ASSOCIATION WITH MYELOMA CAST NEPHROPATHY - A PARANEOPLASTIC VASCULITIS
Munis Mattu, Wamiq Banday, Khalid Qazi, James Ryan, Isoceles Garbes, Barbara Stefanick, Thomas Cumbo; Institution Affiliation: Internal Medicine Training program, Catholic Health System, University at Buffalo, Buffalo, New York, USA
- INTERSTITIAL NEPHRITIS AS THE ONLY RENAL LESION WITH C-ANCA POSITIVE WEGENER’S DISEASE- AN UNUSUAL RENAL PRESENTATION
Muhammad Mustafa, Anjali Acharya, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY
- CRYOGLOBULINEMIC VASCULITIS PRESENTING AS PULMONARY RENAL SYNDROME IN A PATIENT WITH SCLERODERMA
Shyam Parkhie, Sumeska Thavarajah, Francesco Boin; Johns Hopkins Bayview Medical Center, Baltimore, Maryland, USA
- DIFFUSE INFILTRATIVE LYMHOCYTOSIS OF KIDNEYS IN A YOUNG WOMAN WITH HIV AND SLE
Prabodh Ranjan, EH Anjum, H Villanueva, J Yoo, Our Lady of Mercy Medical Center, New York Medical College, NY
- A TRANSCRIPTOMIC APPROACH FOR LUPUS NEPHRITIS CLASSIFICATION
Panduranga Rao1, Celine Berthier1, Viji Nair1, Felix Eichinger1, Anna Henger1, Clemens Cohen2, Matthias kretzler1 and the European renal cDNA bank (ERCB consortium)
1Department of Internal Medicine, University of Michigan, 2University of Zurich-Switzerland
- MPGN AND NEPHROTIC SYNDROME (NS) SECONDARY TO LYME DISEASE (LD)
Bishal Rawal, Leon Rovner, Charuhas Thakar, Judson Pollock, The Jewish Hospital, Cincinnati, OH, USA
- DIFFUSE ALVEOLAR HEMORRHAGE IN A PATIENT WITH HEPATITIS C-ASSOCIATED MIXED CRYOGLOBULINEMIA AND MPO-ANCA POSITIVE FOCAL SEGMENTAL NECROTIZING GLOMERULONEPHRITIS
Shahzad Shafique, Ammar Almehmi; Division of Nephrology, University of Kansas Medical Center, KS
- TYPE 1 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) IN HIV WITHOUT HEPATITIS C (HEP C) CO INFECTION WITH RAPID REMISSION WITH STEROIDS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEI) WITHOUT HIGHLY ACTIVE ANTI RETROVIRAL THERAPY (HAART)
Simi Shahabdeen, Frederick S Fleszler,Dianna C Falkowitz, Mercy Catholic Medical Center, Darby, PA
- SUCCESSFUL TREATMENT OF HENOCH-SCHONLEIN PURPURA NEPHRITIS WITH PLASMA EXCHANGE IN AN ADULT MALE
Ji Young Shin1; Mandeep Singh1, Kunal Chaudhary1,2; Dept. of Medicine, University of Missouri Health Sciences Center and Harry S Truman Veterans Administration Hospital, Columbia, Missouri, USA
- BLEEDING RISK OF PERCUTANEOUS RENAL BIOPSY IN PATIENTS WITH AMYLOIDOSIS
Sandra M. Soares, Donna J. Lager , Morie A Gertz, Fernando C. Fervenza, Nelson Leung, Mayo Clinic, Rochester, MN, USA
- MYCOPHENOLATE MOFETIL (MMF) AS A FIRST LINE AGENT IN THE TREATMENT OF THE GLOMERULAR TIP LESION OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Nicholas Varvarelis, Richard Snyder. Lehigh Valley Hospital Health Network, Allentown, PA USA
- MEMBRANOUS GLOMERULONEPHRITIS IN A PATIENT WITH A CD4+/CD56+ HEMATODERMIC NEOPLASM
Grady M. Wick, Suman Setty, April Brooks, Sujata Gaitonde, Amishi Patel, Christian Sebat, Damiano Rondelli, Jerrold S. Levine, Kalyani Perumal. U. of Illinois at Chicago College of Medicine, Chicago, IL
- MINIMAL CHANGE DISEASE IN ASSOCIATION WITH KIKUCHI-FUJIMOTO DISEASE: FIRST CASE REPORT
Praveen R. Yalamanchili, Sumanth Daram, Hima Boppidi
- FACTORS ASSOCIATED WITH ERYTHROPOIESISSTIMULATING AGENT (ESA) DOSE REQUIREMENTS AND HEMOGLOBIN (HB) RESPONSE IN HEMODIALYSIS (HD) PATIENTS: BASELINE (BL) DATA FROM A PROSPECTIVE OBSERVATIONAL REGISTRY
Irene Agodoa, Jessica Droge, Xiang Ling, Mahesh Krishnan. Amgen Inc., Thousand Oaks, CA, USA.
- THE EFFECT OF BASELINE ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) AND DIABETIC STATUS ON THE EFFICACY OF DARBEPOETIN ALFA IN SUBJECTS WITH CHRONIC KIDNEY DISEASE (CKD)
Paul Audhya, Debra Scarlata, R Kewalramani, Amgen Inc., Thousand Oaks, CA, USA
- EFFICACY OF DARBEPOETIN ALFA (DA) IN HEMODIALYSIS (HD) PATIENTS
Saroj Bhat, Kim Nguyen, jerry Yee, Anatole Besarab, William Poirier, Stanley Frinak, Jennifer Holcomb, Henry Ford Health Systems, Detroit, MI, USA.
- HEMOGLOBIN SC DISEASE IN CHRONIC KIDNEY DISEASE STAGE III, IV AND RARE ESRD REQUIRE CLOSE MONITORING OF HEMOGLOBIN AND FREQUENT TITRATION OF ERYTHROPOIETIN TO AVOID CRISIS AND ANGINA
Jasjot Garcha, Kyle Knuppel, Allan B Schwartz, Ziauddin Ahmed, Allen Friedman* - Drexel University College of Medicine, *Albert Einstein Medical Center, Philadelphia, PA, USA.
- A PROSPECTIVE, CASE-CONTROLLED STUDY OF THE EFFECT OF CONTINUOUS HEMOGLOBIN (HGB) MONITORING (CRITLINE) ON HEMOGLOBIN VARIABILITY (HV) AND ERYTHROPOIETIN (EPO) DOSING
Michael J Germain1, Warren Ho1, Jane Garb1, Cherry Bartlett2, Eric Will2 1Baystate Medical Center, Springfield Ma 2Media Innovations Leeds UK
- CONTINUOUS HEMATOCRIT (HCT) DURING DIALYSIS. RELATIONSHIP OF MAX HCT (MH)TO FINAL HCT (FH)
Michael Germain1 Brian H Nathanson2 Susan Pickard; 1Baystate Medical Center Springfield Ma USA 2Optistatim LLC Longmeadow Ma USA
- FREQUENT HEMOGLOBIN (HGB) MONITORING (12X/MONTH) CAN INFORM CLINICAL AND ORGANISATIONAL DECISION MAKING
Michael J Germain1, Warren Ho1, Jane Garb1, Cherry Bartlett2, Eric Will2 1Baystate Medical Center Springfield Ma 2University of Leeds Leeds England
- INTERIM EVALUATION OF LONG-TERM SAFETY AND TOLERABILITY OF HEMATIDE™ DURING MAINTENANCE TREATMENT OF ANEMIA IN PATIENTS WITH CKD ON HEMODIALYSIS
R Geronemus, M Kaplan, P Pergola, B Schiller, F Whittier, S Wright, R Zabaneh, S Zeig, AM Duliege, R Leong, and A Besarab for the AFX01-09 Study Group
- THE RELATIONSHIP BETWEEN ACHIEVED HEMOGLOBIN (HB) & EXERCISE TOLERANCE
Muirhead N, Keown P, Lei, L Gitlin M, Mayne TJ, Churchill, D. Amgen, Thousand Oaks, CA, USA.
- PROFILES OF SERUM FERRITIN AND TRANSFERRIN SATURATION FOLLOWING ADMINISTRATION OF TWO IV IRON FORMULATIONS TO HEMODIALYSIS PATIENTS
Timothy Nguyen, Holy Name Hospital, Teaneck, NJ
- COMPARISON OF DOSAGE PATTERN OF ERYTRHOPOETIN STIMULATING AGENTS WITH RECOMMENDED DOSE IN HOSPITALIZED PATIENTS
Fazle Noor,Utpal Dutta, Bashar Al Alao, Simi Shahabdeen, Ziauddin Ahmed. Drexel University, College of Medicine. Division of Nephrology, Philadelphia, PA
- ROUTE OF EPOETIN ADMINISTRTION AND HEMOGLOBIN VARIABILITY IN HEMODIALYSIS PATIENTS
tejas patel1, angie hirter2, james kaufman3, sai ram keithi-reddy1, domenic reda2, ajay singh1. 1brigham and women’s hospital, boston, ma, usa; 2hines va hospital, hines, il, usa; 3boston va hospital, boston, ma, usa
- FG2216, A NOVEL ORAL HIF-PHI, STIMULATES ERYTHROPOIESIS AND INCREASES HEMOGLOBIN CONCENTRATION IN PATIENTS WITH NON-DIALYSIS CKD
R Provenzano1, G Fadda2, M Bernardo3, C James4, G Kochendoerfer4, T Lee4, S Nakayama4, T Neff4, BA Piper4; 1St. John Hospital & Medical Center, Detroit, MI, 2California Institute of Renal Research, San Diego, CA, 3Southwest Houston Research, Houston, TX, 4FibroGen, Inc., So San Francisco, CA
- PLATELET COUNT VARIABILITY DURING HEMODIALYSIS
Patt Ryder, Len Usvyat, Jose Diaz-Buxo, Ted Toffelmire, Nathan Levin, Paul M. Zabetakis. Renal Research Institute, New York, NY and Renal Therapies Group, Fresenius Medical Care North America, Waltham, MA.
- EFFECT OF GLYCEMIC CONTROL ON ERYTHROPOIESIS STIMULATING AGENT REQUIREMENT IN DIABETIC MAINTENANCE HEMODIALYSIS PATIENTS
Lon Sadowsky, S. Subramanian, D. Chewaproug, S. Aure, I. Dissanayake, R. Raja
Albert Einstein Medical Center- Philadelphia, Pennsylvania
- VARIABILITY OR COMORBIDITY? EVIDENCE FOR A NULL EFFECT OF HEMOGLOBIN VARIABILITY ON MORTALITY IN HEMODIALYSIS (HD) PATIENTS
Eric Weinhandl1, David Gilbertson1, James Ebben1, Allan Collins1. Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
- CLINICAL PERFORMANCE MEASURE (CPM) FOR ANEMIA BASED ON ACTUAL HEMOGLOBIN (Hb) DISTRIBUTIONS in KY, IN, IL, AND OH
Syed Zaidi and Michael Brier. University of Louisville, Louisville, KY
- ACTIVATED VITAMIN D THERAPY FOR PATIENTS WITH END STAGE RENAL DISEASE ON HEMODIALYSIS: A COST-UTILITY COMPARISON OF EMPIRIC VERSUS USUAL CARE STRATEGIES
Charles B. Arbogast, Stephen W. Olson, Robert M. Perkins, Washington, D.C., USA
- SPONTANEOUS BILATERAL RUPTURE OF QUADRICEPS TENDON IN A DIALYSIS PATIENT WITH SECONDARY HYPERPARATHYROIDISM
Robin Arora, Saud Javed. James J Peters VA Medical Center, Bronx, NY, USA
- RELATIONSHIP OF CALCIUM INTAKE WITH SERUM CALCIUM LEVEL
Ms. Fiona Byrne, Dr Sinead Kinsella and Dr JA Eustace. Cork University Hospital, Cork, Ireland
- USE OF BEHAVIORAL MODELING IN PATIENT-TAILORED EDUCATION ON PHOSPHOROUS CONTROL
Hafez Elzein, Sana Ghaddar. Wael Shamseddine American University of Beirut, Beirut – Lebanon
- ACTIVE VITAMIN D ANALOGUES DO NOT DIRECTLY AFFECT VASCULAR SMOOTH MUSCLE CELL CALCIFICATION, BUT INDUCE A PROCALCIFIC TO ANTICALCIFIC PARACRINE SWITCH IN CO-CULTURED HUMAN MACROPHAGES
Cecilia M. Giachelli Xianwu Li, Mohga El-Abbadi; University of Washington, Seattle, WA USA
- “PHOSGRAPH”: A NOVEL METHOD OF IMPROVING PATIENT COMPLIANCE AND PHOSPHATE CONTROL BY EDUCATION AND COMPETITION
Harnett PR, Ramlan G, Chandrasekaren L, Jones M, Almond MK
- CONVERTING FROM PARICALCITOL INJECTION TO DOXERCALCIFEROL CAPSULES IN CKD PATIENTS ON HD: A RANDOMIZED, OPEN-LABEL STUDY TO DETERMINE CLINICALLY APPROPRIATE DOSES
J. Hertel, MD, Nephrology Associates, Augusta GA; S. Hariachar, MD, Outcomes Research International, Hudson, FL; A. Gonzalez, MD, Renal Endocrine Associates, P.C., Pittsburgh, PA
- CONVERTING FROM DOXERCALCIFEROL INJECTION TO DOXERCALCIFEROL CAPSULES IN CKD PATIENTS ON HD: A RANDOMIZED, OPEN-LABEL STUDY TO DETERMINE CLINICALLY APPROPRIATE DOSES
K.Shashi Kant, University of Cincinnati College of Medicine, Cincinnati, OH; Marializa Bernardo, Southwest Houston Research, LTD, Houston, TX; Alejandro R. Gonzalez, Renal Endocrine Associates, P.C., Pittsburgh, PA
- COMPARISON OF HEMODIALYSIS PATIENT OUTCOMES FOLLOWING TREATMENT WITH PARICALCITOL ALONE OR IN COMBINATION WITH CINACALCET
Maria Karalis, Nana Wiafe and Dennis Andress, Abbott Laboratories, Abbott Park, IL, USA
- OPEN LABEL, PLACEBO-CONTROLLED, RANDOMIZED, SINGLE DOSE ESCALATION AND REPEAT DOSE STUDY OF INTRAVENOUS CTA018 IN HEALTHY VOLUNTEERS
Jukka Karjalainen1, Jeffery Warren1, Joel Z Melnick1 and Jonathan Willmer2; 1Cytochroma Inc. Markham, Ontario, Canada; 2CANTEST Clinical Research, Vancouver, British Columbia, Canada.
- FATAL CALCIPHYLAXIS IN A HEMODIALYSIS DEPENDANT 51Y/O FEMALE WITH ESRD DUE TO DIABETIC NEPHROPATHY
Jagan Kothapally, David C. Yoburn , Jeffrey Clement; Memorial Hospital of Rhode Island, Pawtucket, RI, United States
- MEDICAL COSTS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH DIABETES: A MANAGED CARE PERSPECTIVE
François Laliberté1, Brahim Bookhart2, Francis Vekeman1, Mitra Corral2, Mei-Sheng Duh3, Robert A. Bailey2, Patrick Lefebvre1
1Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC, Bridgewater, NJ, USA; 3Analysis Group, Inc., Boston, MA, USA
- EFFECTS OF USE PATTERNS OF INTRAVENOUS VITAMIN D ON ALL-CAUSE MORTALITY IN PREVALENT HEMODIALYSIS PATIENTS
Shuling Li, Wendy L St. Peter, Jiannong Liu, David T. Gilbertson, Tom J Arneson, Allan J Collins. Chronic Disease Research Group, Minneapolis, MN, USA
- ASSOCIATION OF HCO3 AND PHOSPHATE WITH PTH LEVELS (iPTH, CAP, CIP and tPTH) IN A HEMODIALYSIS COHORT
Mohan S, Cheng JT, Pogue VA, Park CM. Dept of Medicine, Harlem Hospital Center , Columbia University, New York, NY
- ETHNIC DIFFERENCES IN PTH AND MINERAL METABOLISM IN PATIENTS RECEIVING CHRONIC HEMODIALYSIS
Mohan S, Cheng JT, Pogue VA, Park CM. Dept of Medicine, Harlem Hospital Center, Columbia University, New York, NY
- STAYING ALIVE WITH SERUM PHOSPHORUS≤5.5; A MULTIDISCIPLINARY TEAM CAMPAIGN WITH TWO HEMODIALYSIS CLINICS TO IMPROVE PHOSPHORUS OUTCOMES
Cecelia Pesa, Kim Gehrke, Carol Gee Shak, RAI; Oakland/San Leandro, CA.
- CORONARY ARTERY CALCIUM SCORE, INFLAMMATION AND MORTALITY IN MAINTENANCE HEMODIALYSIS PATIENTS
Ronney Shantouf, MD1; Naser Ahmadi, MD3, Mehdi Rambod, MD1, Ferdinand Flores3, Jima Tiano3, Matthew Budoff, MD3; and Kamyar Kalantar-Zadeh1,2. 1Harold Simmons Center for Kidney Disease Research & Epidemiology, 2Division of Nephrology, and 32Cardiology, LABioMed at Harbor-UCLA, Torrance, CA
- A DIETARY ALTERNATIVE TO PHOSPHORUS CONTROL
Lynn Taylor, Carroll County Dialysis Center, DaVita, Inc.; Westminster, Maryland, USA
- EVALUATION OF FACTORS AFFECTING THE ADEQUACY OF HEMODIALYSIS IN ACUTE SETTING
Mersema Abate, Siddharth Bhatt, Davinder Wadehra, Nand K Wadhwa, Division of Nephrology, SUNY, Stony Brook, NY
- EFFECT OF ULTRAFILTRATION ON AORTIC AUGMENTATION PRESSURE AND INDEX IN PATIENTS ON MAINTENANCE HEMODIALYSIS
Shaun Aure, Elizabeth Gersbach, Madhu Kandarpa, Lon Sadowsky, Daranee Chewaproug, Craig Oliner, William Gaughan, Imara Dissanayake, Eric Bloom, Albert Einstein Medical Center, Philadelphia, PA
- RESOLUTION OF CAST NEPHROPATHY FOLLOWING FREE LIGHT CHAIN REMOVAL BY HEMODIALYSIS IN A PATIENT WITH MULTIPLE MYELOMA
Kolitha Basnayake1, Colin Hutchison1, Dia Kamel1, Michael Sheaff2, Neil Ashman2, Heather Oakervee2, Mark Cook1, Arthur Bradwell3, Paul Cockwell1.
1Queen Elizabeth Hospital, Birmingham, 2Barts and the London NHS Trust, London, 3University of Birmingham, Birmingham, UK
- TESTICULAR ANGINA ON DIALYSIS: A NOVEL PRESENTATION WHILE ESTABLISHING DRY WEIGHT
Buffington, Mary; Sequeira, Adrian; Isaac, Prasanna; Bahta, Elias
- MASTERING HEMODIALYSIS TO REVERSE PATTERNS OF MISSED AND SHORTENED TREATMENTS
Jessica Cabness1, Cindy Miller2, Kristin Martina2. 1University of South Florida, School of Social Work, Tampa, FL, 2USF Dialysis Center, Tampa, FL
- PLASMA B 6 VITAMERS IN HEMODIALYSIS SUBJECTS TAKING PRESCRIPTION OR OVER-THE-COUNTER RENAL MULTIVITAMIN SUPPLEMENTS
Clement, Louise; Boylan, Mallory; Miller, Virginia; Driskell, Judy; and Giraud, David. South Plains Kidney Disease Center; Texas Tech University and Texas Tech University Health Sciences Center, Lubbock, TX, and University of Nebraska, Lincoln, NE, USA
- IMPACT OF A SOCIAL SUPPORT GROUP
INTERVENTION IN ESRD PATIENTS
Scott D. Cohen*, Brenna Clougherty**, Prashant Khetpal*, Sholey Argani***, Gloria Wiggs***, Rolf A. Peterson****, Paul L. Kimmel*
*Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University,**George Washington University School of Medicine,***Washington DC VA Medical Center, Renal Section,****George Washington University, Psychology
- A RETROSPECTIVE REVIEW OF PERIOPERATIVE MANAGEMENT OF SERUM POTASSIUM MEASUREMENTS IN CHRONIC HEMODIALYSIS PATIENTS
Clenton Coleman, Harminder Sandhu Maria Devita Lenox Hill Hospital Department of Nephrology New York NY
- HYPOALBUMINEMIA SEVERITY PREDICTS INTRADIALYTIC PARENTERAL NUTRITION (IDPN) EFFECTIVENESS IN HEMODIALYSIS PATIENTS
Arezu Dezfuli, MD1, Michelle Ricker, RD2; Deborah Scholl, RD2; Stanley M Lindenfeld, MD2; and Kamyar Kalantar-Zadeh, MD PhD1,2; 1Harold Simmons Center for Kidney Disease Research & Epidemiology, Harbor-UCLA, Torrance, CA; and 2Pentec Health, Boothwyn, PA
- MORTALITY TREND OF HEMODIALYSIS CHAINS IN THE USA: 1996-2004
Uyen Duong, MD MPH1,2, Kamyar Kalantar-Zadeh, MD PhD1,2, Csaba Kovesdy, MD3. Rajnish Mehrotra, MD2. 1Harold Simmons Center for Kidney Disease Research & Epidemiology, 2Division of Nephrology, LABioMed at Harbor-UCLA, Torrance, CA; and 3VA, Salem, VA
- ACUTE HEPATITIS B INFECTION IN A HEMODIALYSIS PATIENT DESPITE PERSISTENT NATURAL IMMUNITY
Jennifer Ennis and Nicole Stankus, University of Chicago Medical Center, Chicago, IL, USA
- POTENTIAL INTERACTION BETWEEN MIDIDRINE AND LINEZOLID
Ramy Fayad, Jerry Yee, Nizar Attallah; Division of Nephrology and Hypertension, Henry Ford Hospital; Detroit, Michigan (USA)
- BEHAVIORAL MODELING TO GUIDE PATIENT’S ADHERENCE TO FLUID CONTROL
Sana Ghaddar, Wael Shamseddine, Hafez Elzein. American University of Beirut, Beirut – Lebanon
- ESTIMATION OF EPTIFIBATIDE CLEARANCE BY DIALYSIS USING AN IN VITRO SYSTEM
Joanna Q. Hudson1,2, Christie A. Green2, Elizabeth A. Beach1, Lisa K Jennings2. University of TN Departments of Clinical Pharmacy and Medicine, Memphis, TN, USA
- PREDICTING DRUG REMOVAL BY DIALYSIS USING AN IN VITRO SYSTEM
Joanna Q. Hudson, Elizabeth A. Beach. University of TN Department of Clinical Pharmacy, Memphis, TN, USA
- HIGH RENAL RECOVERY RATE FROM CAST NEPHROPATHY FOLLOWING FREE LIGHT CHAIN REMOVAL HEMODIALYSIS
Colin A Hutchison1, Kolitha Basnayake1, Mark Cook2, Paul Cockwell1, Arthur R. Bradwell3. Departments of 1Renal Medicine and 3Hematology, Queen Elizabeth Hospital, QEMC, Birmingham, UK; 2Division of Immunity and Infection, Medical School, University of Birmingham, Birmingham, UK
- INACCURACY OF BLOOD PRESSURE (BP) MEASUREMENTS (Mm) BEFORE HEMODIALYSIS (HD) TREATMENTS (RX)
Paul G. Jenkins and Marilyn Nuens, ARA Milwaukee Dialysis Center, Milwaukee, WI, USA
- HOMOCYSTEINE LOWERING EFFECT OF ADSORPTIVE DIALYSIS MEMBRANES: A MULITCENTER, RANDOMIZED, OPEN STUDY
Amir Kazory*, Marc Kribs, Véronique Fournier, Gérard Motte, Claude Guy, Nadège Devillard, Maria Yannaraki, Gilbert Zanetta, Jean-Marc Chalopin, Véronique Fayol, Didier Ducloux* ; * Department of Nephrology, Dialysis, and Renal Transplantation, University of Franche-Comté, Besançon, France
- NO IMPROVEMENT IN CREATININE DESPITE DIALYSIS WHEN POISONED
Jayapriya Krishnaswamy, M. Atiq Dada and Nancy Adams; University of Connecticut Health Center, Division of Nephrology, Farmington, Connecticut
- ASSESSMENT OF EXTRACELLULAR FLUID VOLUME IN HEMODIALYSIS PATIENTS BY USING CALF BIOIMPEDANCE SPECTROSCOPY
Li Liu, Jochen Raimann, Grzegorz Wystrychowski, Shaunak Dwivedi, Fansan Zhu, Peter Kotanko, Nathan W. Levin, Renal Research Institute, New York, NY, USA
- INCREASING THE CLEARANCE OF PROTEIN-BOUND SOLUTES BY INCREASING DIALYZER MASS TRANSFER AREA COEFFICIENT (KoA)
AND DIALYSATE FLOW (Qd)
Frank Luo, Kajal Patel, Natalie Recht, & Timothy Meyer. Stanford University and VA Palo Alto HCS, Stanford, CA, USA
- PULMONARY HYPERTENSION IN AN INNER CITY ESRD POPULATION ON HEMODIALYSIS: PREVALENCE, RISK FACTORS FOR, AND ASSOCIATIONS WITH MORTALITY
Meyer A, Turner J, Melamed M, Hostetter T, Raff A. Albert Einstein College of Medicine, Bronx, NY, USA
- TIME-DEPENDENT ASSOCIATION BETWEEN DIALYSIS DOSE AND 5-YEAR SURVIVAL IN CONTEMPORARY MAINTENAMCE HEMODIALYSIS PATIENTS
Jessica E Miller1, Elani Streja1, Csaba Kovesdy3, Charles J McAllister4, David Van Wyck4, Joel D Kopple2, and Kamyar Kalantar-Zadeh12.
1Harold Simmons Center for Kidney Disease Research & Epidemiology, 2Harbor-UCLA, Torrance, CA 3VA,Salem, VA; 4DaVita, El Segundo,CA
- SERUM FRUCTOSAMINE (SF) AND GLYCOSYLATED HEMOGLOBIN (HbA1c) AS PREDICTORS OF HOSPITALIZATION AND INFECTION IN DIABETIC HEMODIALYSIS PATIENTS (PTS)
Neal Mittman, Hiteshkumar Kapupara, Namrita Baveja, Irfan Fazil, Brinda Desiraju, Morrell M. Avram. Avram Division of Nephrology, Long Island College Hospital, Brooklyn, NY, USA
- ASSOCIATION BETWEEN INFLAMATION AND MALNUTRITION IN HEMODIALYSIS (HD) PATIENTS
Moreira, PR, Librelotto CS, Bundchen PL, Rosa DF, Sperotto RL, Ticiane R, Sturmer G, Rizzi C. Cruz Alta University, Brazil
- MANAGEMENT AND TOXICOKINETICS OF METFORMIN ASSOCIATED LACTIC ACIDOSIS (MALA) BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF)
Mujtaba M, Madhrira M, Agarwala R, Mohan S, Park C, Anderson H, Pogue V, Cheng JT. Harlem Hospital Center, Columbia University NY
- HEMODIALYSIS NONADHERENCE: BIMODAL SEASONAL VARIATION IN ATTENDANCE AT AN URBAN CENTER
Chamberlain I. Obialo1, Khalid Bashir1, Sharon Goring2, Judith Alexander-Squires2, Beverly Robinson2, Alexander Quarshie3. 1Renal and 3Biostatistics Section, Morehouse School of Medicine, Atlanta, GA; 2Dialysis Clinics Inc, Atlanta, GA
- COMBINED EFFECTS OF IRON AND GADOLINIUM AS A RISK FACTOR FOR THE DEVELOPMENT OF NEPHROGENIC SYSTEMIC FIBROSIS
Mandip Panesar, Frank Boateng, Syed Masood, Munis Mattu, Brian Murray. University at Buffalo, Buffalo, New York, United States
- A CASE OF EXTREME METABOLIC ALKALOSIS IN HEMODIALYSIS PATIENT
Minesh Pathak, Lajos Zsom, Tibor Fulop, University of Mississippi Medical Center, Jackson, Mississippi
- SERUM-CONDUCTIVITY IMPACTS BIOIMPEDANCE SPECTROSCOPY (BIS)
J. Raimann, L. Liu, AT. Morris, F. Zhu, P. Kotanko, N. Levin
- QUALITY OF LIFE (QOL) AND LIFE SATISFACTION OF PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS THRICE A WEEK IN INDIA
Sujata Rajapurkar, Jincy Vergese, Muljibhai Patel; Urological Hospital, Nadiad, Gujarat, India
- MORTALITY PREDICTABILITY OF SERUM PREALBUMIN IN MAINTENANCE HEMODIALYSIS PATIENTS IN A 5-YEAR COHORT
Mehdi Rambod, MD1; Csaba P Kovesdy, MD3, Joel D Kopple2, and Kamyar Kalantar-Zadeh1,2. 1Harold Simmons Center for Kidney Disease Research & Epidemiology, 2Division of Nephrology, LABioMed at Harbor-UCLA, Torrance, CA; and 3VA Med. Center, Salem, VA.
- REMOVAL OF ADVANCED GLYCATION END PRODUCTS WITH A NOVEL EXTRACORPOREAL BIOADSORBENT REDUCES THE MONOCYTE INFLAMMATORY RESPONSE
Stuart M. Sprague, Elaine Zhang, Cynthia Daniels, Guillermo Ameer; Northwestern University and Evanston Northwestern Healthcare, Evanston, Illinois, USA
- DOCUMENTED INFECTION AND NUTRITIONAL STATUS
Jessica Stauffer, Monica Serra, Maureen McCarthy, Kamyar Kalantar-Zadeh, Janeen Leõn, Alison Steiber
- DOES NURTITION AND INFLAMMATION STATUS ACCOUNT FOR GREATER SURVIVAL IN BLACK MAINTENANCE HEMODIALYSIS PATIENTS?
Elani Streja1, Rulin Cai Hechter1, Csaba Kovesdy3, John Robertson4, Charles J McAllister4, Joel D Kopple2, and Kamyar Kalantar-Zadeh1,2; 1Harold
Simmons Center for Kidney Disease Research & Epidemiology, 2Harbor-UCLA, Torrance,CA; 3VA, Salem,VA; 4DaVita,El Segundo,CA
- SEVELAMER HYDROCHLORIDE USE AND CIRCULATING ENDOTOXIN AND INFLAMMATORY BIOMARKERS IN HEMODIALYSIS PATIENTS: A PRELIMINARY REPORT
Phyllis P Sun, Mary C Perianayagam, Bertrand L Jaber. Division of Nephrology, Caritas St. Elizabeth’s Medical Center, Boston, MA
- INTERDICIPLINARY COLLABORATIVE TO ENSURE WATER SAFETY FOR HEMODIALYSIS PATIENTS
Mary Anne Szestak, Bhavesh Patel, Alyshia Smith; Washington Hospital Center, Washington D.C., USA
- HEPATITIS C VIRUS (HCV) TRANSMISSION IN THE HEMODIALYSIS SETTING: IMPORTANCE OF INFECTION CONTROL PRACTICES AND ASEPTIC TECHNIQUE
Nicola Thompson and Stephanie Bialek. CDC, Atlanta, GA. USA
- OPTIMAL TIME OF BLOOD SAMPLING FOR PT/PTT/INR IN HEMODIALYSIS PATIENTS WITH CATHETER LOCKED WITH HEPARIN OR CITRATE
Davinder Wadehra, Ajay Patel, Mersema Abate, Heesuck Suh, Nand K Wadhwa, Division of Nephrology, SUNY, Stony Brook, NY
- DESIGNING A PERSONAL DIGITAL ASSISTANT (PDA) APPLICATION TO SELF-MONITOR DIET & FLUID INTAKE
Janet L. Welch1, Kay Connelly2, Katie Siek3, Josette Jones4, Susan M Perkins5, Beenish Chaudry2, Laurie Trevino6 1Indiana University School of Nursing, Indianapolis, IN. 2Indiana University Department of Computer Science, Bloomington, IN. 3University of Colorado Department of Computer Science, Boulder, CO. 4Indiana University, School of Informatics, Indianapolis, IN. 5Indiana University School of Medicine, Division of Biostatistics, Indianapolis, IN. 6Clarian Health Partners, Department of Nutrition & Dietetics, Indianapolis, IN.
- INTERACTION OF RACE AND OBESITY ON THE SHORT-TERM SURVIVAL OF ESRD PATIENTS
Roderic Woodson, Janice Lea, William McClellan; Emory University, Atlanta, Ga USA
- EFFECT OF DIFFERENT TYPES OF ACCESS ON CHANGES IN AORTIC AUGMENTATION PRESSURE AND INDEX IN A SINGLE HEMODIALYSIS SESSION
Shaun Aure, Elizabeth Gersbach, Srinivas Subramanian, Lon Sadowsky, Daranee Chewaproug, Craig Oliner, William Gaughan, Imara Dissanayake, Eric Bloom, Albert Einstein Medical Center, Philadelphia
- PERCUTANEOUS THROMBECTOMY OF ARTERIOVENOUS FISTULAS IN HEMODIALYSIS PATIENTS: A SINGLE-CENTER EXPERIENCE
Gaurav Jain, Ivan D. Maya, Michael Allon, Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama
- ACCESSS MONITORING STRATEGY AND LONG TERM SURVIVAL
Sonja Kapun, Krsko, Slovenia
- TYPE OF FISTULA, NYHA CLASS AND APELIN, NEWLY DISCOVERED ADIPOCYTOKINE IN HEMODIALYZED PATIENTS.
Jolanta Malyszko, Jacek Malyszko, Piotr Kozminski, Slawomir Wolczynski, Michal Mysliwiec. Department of Nephrology and Transplantology, Medical University, Bialystok Poland
- COMPARISON OF OUTCOMES OF TRANSPOSED UPPER ARM FISTULAS, BRACHIOCEPHALIC FISTULAS, AND UPPER ARM GRAFTS IN HEMODIALYSIS PATIENTS
Jeremy O’Neal, Ivan D. Maya, Michael Allon, Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama
- EVALUATION OF ANTIBIOTIC LOCK TREATMENT FOR ENTEROCOCCUS CATHETER RELATED BACTEREMIA IN HEMODIALYSIS PATIENTS.
William J. Peterson, Ivan D. Maya, Michael Allon. University of Alabama at Birmingham/ Div Nephrology/ Department of Medicine. Birmingham. AL
- USE OF TUNNELLED CATHETERS IN HEMODIALYSIS
Vaibhav Sahni, Bashar Alalao, Jasjot Garcha, Joseph Saggio, Ziauddin Ahmed
Drexel University College of Medicine, Philadelphia
- ISCHEMIC MONOMELIC NEUROPATHY
Gautham Viswanathan, Sankar D Navaneethan. Medicine, St.Catherine Hospital, East Chicago, IN and Nephrology, University of Rochester, Rochester, NY
- EVALUATION OF THE SAFETY OF FERUMOXYTOL IV IRON THERAPY IN PERITONEAL DIALYSIS PATIENTS
WK Bolton1, L Brenner2, J Dioguardi2, F Finkelstein3
1Univ of VA Health System, Charlottesville, VA; 2AMAG Pharmaceuticals, Inc. Cambridge, MA; 3Metabolism Associates, New Haven, CT
- COMPARING MORTALITY OF CHRONIC PERITONEAL AND MAINTENANCE HEMODIALYSIS PATIENTS IN THE 21ST CENTURY UP TO 5 YEARS
Rulin Cai Hechter1, Elani Streja1, Rajnish Mehrotra2, Csaba Kovesdy3,
Charles J McAllister4, John Robertson4, Joel D Kopple2, Jennie Jing1, and Kamyar Kalantar-Zadeh1,2; 1Harold Simmons Center for Kidney Disease Research & Epidemiology, 2Division of Nephrology, LABioMed at Harbor-UCLA, Torrance, CA; 3VA, Salem, VA; 4DaVita, Inc, El Segundo, CA.
- VARIATION IN PERITONEAL DIALYSIS (PD) UTILIZATION AMONG LARGE DIALYSIS ORGANIZATIONS (LDOs): AN EXPLANATION FOR PD DECREASE?
Osman Khawar1,2, Kamyar Kalantar-Zadeh1,2, Uyen Duong1,2, Linda Fried4, Keith Norris2,3, Allen Nissenson2 and Rajnish Mehrotra1,2; 1LA BioMed at Harbor-UCLA, Torrance, CA, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, 3Charles Drew University, Los Angeles, CA, 4VA Pittsburgh Health Care System, Pittsburgh, PA
- A CASE OF ENDOSCOPY-RELATED PERITONITIS IN A PERITONEAL DIALYSIS PATIENT
Minesh Pathak, Tibor Fulop. University of Mississippi Medical Center, Jackson, Mississippi
- IMPROVED NUTRITION DURING NOCTURNAL HEMODIALYSIS
Sikkes M.E, Weijs P.J.M , Doezie I, Hoogenstraaten A, Kooistra M.P.
- ALBUMINURIA IN OBESE ADULTS IS ASSOCIATED WITH HYPERTENSION AND SLEEP DISTURBANCE
Varun Agrawal, Thomas E. Vanhecke, Barry A. Franklin, Kerstyn C. Zalesin, R. Bart Sangal, Basil Hakmeh, Adam T. deJong, Peter A. McCullough, William Beaumont Hospital, Royal Oak MI, USA
- AORTIC STIFFNESS IN GLOMERULONEPHRITIS CHRONIC KIDNEY DISEASE COMPARED TO OTHER CKD ETIOLOGIES
Sridhar Reddy Allam, Yin Ping Liew, Susana Arrigain, Mohammed Rafey, and Martin J Schreiber; Cleveland Clinic Foundation, Cleveland, OH, USA
- KNOCKOUT OF THE GLUCOCORTICOID RECEPTOR IN THE DISTAL NEPHRON DOES NOT AFFECT DEXAMETHASONE-INDUCED HYPERTENSION
Julie Goodwin1, Junhui Zhang2, David Geller2 1Section of Nephrology, Department of Pediatrics, Yale University School of Medicine 2Section of Nephrology, Department of Medicine, Yale University School of Medicine
- PODOCYTURIA IN PRE-ECLAMPSIA AND PATIENTS AT HIGH RISK FOR PRE-ECLAMPSIA
Samia Mian, Belinda Jim. University of Illinois, Oak Lawn, IL USA
- BIOCHEMICAL MARKERS AND LIPID PROFILES IN A MULTIETHNIC HYPERTENSIVE POPULATION FROM THE UNITED ARAB EMIRATES.
Enyioma Obineche1, Javid Pathan1, Rhesa Obineche2, Abdishakur Abdulle1
1Department of Medicine; Faculty of Medicine, UAE University; United Arab Emirates, 2Comenious Medical School, Bratislava, Slovak Republic
- BLOOD PRESSURE (BP) CONTROL IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) IN THE SETTING OF A NURSE PRACTITIONER (NP) MANAGED CKD CLINIC MODEL
Naima Ogletree, Schawana Thaxton, Jerry Yee, Sandeep Soman. Henry Ford Hospital, Detroit, MI, USA
- COST-EFFECTIVENESS OF ALISKIREN AS ADD ON TO LOSARTAN AND OPTIMAL ANTIHYPERTINSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE UK SETTING
James L Palmer1, Veronica C Munk2, Robert W Kotchie3, Gabor Vincze2, Alan Charney4, Daniel MD Tucker1, Lieven Annemans5 1IMS Health, Basel, Switzerland, 2 Novartis Pharma AG Basel, Switzerland, 3IMS Health, London, UK, 4Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, 5Ghent University, Ghent, Belgium
- SMOKING ASSOCIATED NODULAR GLOMERULOSCLEROSIS
Aniruddha Palya, Aparna Subbaraman, Simi Shahabdeen, Dianna Falkowitz, Shalini Vijaykumar
- HYPERTENSION AND CHRONIC KIDNEY DISEASE: KEEP AND NHANES
Madhav V. Rao1, Yang Oiu2, Changchun Wang2, George Bakris13.
1Department of Medicine, Section of Nephrology, University of Chicago, Pritzker School of Medicine, Chicago, Illinois, 2Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, 3Hypertensive Diseases Unit, Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Pritzker School of Medicine, Chicago, Illinois
- REGULATION OF CALCITROPIC HORMONE IN AFRICAN AMERICAN WITH HYPERTENSION
Alicia Romero, Robert Beach, Vivien Yoon, Lori Trout, Hussein Galani, B.J. Blow. UTMB, Galveston, Texas, United States
- AN UNUSUAL CAUSE OF MALIGNANT HYPERTENSION
Zakaria Saleem, Phillip Habib, Christopher Valentine, Ganesh Shidham, Anil Agarwal. Ohio State University, Columbus, Ohio, USA
- COMPARISON OF ANKLE BP WITH BRACHIAL BP MEASUREMENT IN DIALYSIS PATIENTS BY AUTOMATIC OSCILLOTONOMETRY
Sudhir Vyakaranam, Jayakrishnan Krishnakurup, Ravi Desi, Shah Mukhtadir, Ziauddin Ahmed; Drexel University College of Medicine, Philadelphia, Pennsylvania
- DIRECT RENIN INHIBITOR FOR THE TREATMENT OF HYPERTENSION: A SYSTEMATIC REVIEW
Gautham Viswanathan.Medicine, St.Catherine Hospital, East Chicago, IN
- DIFFUSION WEIGHTED IMAGING EVALUATE RENAL FUNCTION IN PATIENT WITH HYPERTENSION RENAL DAMAGE
B.J. Xie, X.B. Zhang*, J. Zhang*; Department of Radiology, and *Department of Surgery, Division of Urology, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
- LACK OF ASSOCIATION BETWEEN CHRONIC HEPATITIS C VIRUS INFECTION AND CHRONIC KIDNEY DISEASE
Sumeet Asrani1; Mark Schnitzler2; Brett Pinsky2; Lisa A. Rocca Rey2,3; Fasiha Kanwal2. 1. Washington University School of Medicine, Saint Louis, MO, USA.; 2. Saint Louis University School of Medicine, Saint Louis, MO, USA; 3. University of Milan, Milan, Italy
- NEPHROLOGY SOCIAL WORK SALARIES, PATIENT CASELOADS, AND IMPLICATIONS FOR CKD CARE IN THE UNITED STATES
Teri Browne1, Joseph Merighi2, Aaron Herold3; 1, 3Council of Nephrology Social Workers; 2Boston University
- CALCIFIC UREMIC ARTERIOLOPATHY (CUA) SUCCESSFULLY TREATED WITH INTRAVENOUS SODIUM THIOSULPHATE
Ion D Bucaloiu MD1, Evan Norfold MD2, Nektarios Lountzis MD3 , Fred O Miller MD3, Dirk Elston MD3
- CHANGES IN THE POTASSIUM CONTENT OF DIFFERENT POTATO VARIETIES AFTER COOKING
Jerrilynn D. Burrowes and Nicholas J. Ramer, C.W. Post Campus of Long Island University, Brookville, NY, USA
- VASCULAR CALCIFICATIONS INDENTIFIED ON SCREENING MAMMOGRAPHY ARE ASSOCIATED WITH CHRONIC RENAL FAILURE
Paul S. Dale, Amy Loden, Gavin Mackie, Mike Richards, Ellis Fischel Cancer Center/University of Missouri School of Medicine. Columbia, MO, USA
- THE MANAGEMENT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE.
Vera Dounaevskaia1, DiMeglio1, Ron Wald1 1St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
- RISK FACTORS FOR ACCELERATED LOSS OF GFR IN ADVANCED CHRONIC KIDNEY DISEASE (CKD)
Kevin Erickson, Emory University SOM, Atlanta, GA, Janice Lea, Emory University SOM, Atlanta, GA, William McClellan, Emory University SOM, Atlanta, GA, Tom Greene, Cleveland Clinic Foundation, Cleveland, OH, Lawrence Appel, Johns Hopkins University, Baltimore, MD, Keith Norris, King-Drew Medical College, Los Angeles, CA
- CHRONIC KIDNEY DISEASE IS SIGNIFICANTLY UNDERRECOGNIZED AMONG VA PRIMARY CARE USERS
Michael Fischer1,2, Grady Wick1,2, Kevin Stroupe2,3, Denise Hynes2,4, Margaret Browning2, Zhiping Huo3, James Kaufman5. 1Medicine, Jesse Brown VAMC/U. Illinois, Chicago, IL; 2Center for Management of Complex Chronic Care, Hines VA, Hines, IL; 3Northwestern U., 4Medicine, Loyola U., Chicago, IL and 5Medicine, Boston VAMC/Boston U., Boston, MA.
- AN INNOVATIVE STRATEGY TO RESTORE RENAL FUNCTION IN CHRONIC KIDNEY DISEASE
Narisa Futrakul, Prasit Futrakul. King Chulalongkorn Memorial Hospital, Bangkok,Thailand
- CHRONIC KIDNEY DISEASE AS PREDICTOR OF WORSE OUTCOMES AMONG PATIENTS WITH CARDIAC INSUFFICIENCY STAGES B AND C
Arise Galil, Hélady Pinheiro, Darcília Costa and Marcus Bastos
NIEPEN of Federal University of Juiz de Fora and Fundação IMEPEN, Juiz de For a (MG), Brazil
- PLATELET FUNCTION ANALYSER-100 (PFA-100) MONITORING DOES NOT PREDICT BLEEDING AFTER PERCUTANEOUS KIDNEY BIOPSY.
Benahili Iboaya, Nahid Islam, Frederick Lee, Eric Miller, Christopher Mire, Darren Schmidt, Tibor Fulop. University of Mississippi Medical Center, Jackson, MS
- CALCEMIC UREMIC ARTERIOLOPATHY -WIDE EXCISION IS A PROMISING CURATIVE APPROACH: CASE REPORT AND LITERATURE REVIEW
Deepak Jasuja ,Thomas Powell ,Alice Rocke and Donna Finegan, University of Pittsburgh, Pittsburgh, PA, USA
- INCREASED RISK OF PERIPHERAL ARTERIAL DISEASE WITH INCREASING ALBUMIN/CREATINE RATIO AND DECREASED GFR
Nelson P. Kopyt, James F. Reed III
- PREVALENCE OF PROTEINURIA IN THE U.S. ADULT POPULATION: RESULTS FROM NHANES SURVEYS (2001-2004)
Nelson P. Kopyt, James F. Reed III
- NEPHROMEGALY, INTERSTITIAL NEPHRITIS, AND COMMON VARIABLE IMMUNODEFICIENCY
Jorge Lamarche, Alfredo Peguero, Craig Courville, Schartess Culpepper and Luis Beltran James A. Haley Veteran’s Hospital and University of South Florida Tampa, Florida, USA
- COGNITIVE DECLINE, DEPRESSION AND QUALITY OF LIFE IN PATIENTS IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE
Simone de Lima, Natália Fernandes, Fabiane dos Santos, Márcia Peruzzi and Marcus Bastos; NIEPEN da UFJF e Fundação IMEPEN, Juiz de Fora (MG) - Brazil
- PULSE PRESSURE AS A PREDICTOR OF CHRONIC KIDNEY DISEASE PROGRESSION
A. Bilal Malik, Melissa Shannon, Lavanya Amuluru, Irfan Kundi, M. Gohar Alam.
University of Arkansas for Medical Sciences and the Central Arkansas Veterans’ Healthcare System, Little Rock, AR
- PREDICTION OF PROGRESSION OF DIABETIC NEPHROPATHY IN A SMALL SET OF PATIENTS BY ARTIFICIAL NEURAL NETWORKS AND PROTEOMIC ANALYSIS
Mohammad Mataria1,2, Michael G. Janech2, Jonas Almeida3, Evelyn Lewis1,2 Alison Bland2, John Arthur1,2 1Ralph H. Johnson, VAMC, Charleston, SC; 2MUSC, Charleston, SC; 3University of Texas MD Anderson Cancer Center, Houston, Texas.
- PREDICTORS OF LATE REFERRAL AFTER THE IMPLEMENTATION OF K-DOQI GUIDELINES
Sankar D Navaneethan, Vinodh Jeevanantham, Scott Liebman. Nephrology, University of Rochester, Rochester, NY and Medicine, Wake Forest University, Winston-Salem, NC
- OUTCOMES ASSOCIATED WITH HYPERURICEMIA IN CHRONIC KIDNEY DISEASE
Jude O Ojie, Sajid M George, Smriti Sharma, Alan Brijbassie, Kamyar Kalantar-Zadeh, Csaba P Kovesdy; Nephrology, Salem VA Medical Center, Salem, VA; Internal Medicine, Carilion Clinic, Roanoke, VA; Harbor-UCLA, Torrance, CA, United States
- ROLE OF RENIN ANGIOTENSIN SYSTEM (RAS) IN ANEMIA RELATED TO CHRONIC KIDNEY DISEASE (CKD)
Aniruddha Palya, Fazle Noor, Frederick Fleszler, Simi Shahabdeen, Racquel David, Niyati Modi, Sachin Shrestha, Zecharias Berhane, Ajay Kumar, Dae Hwan Kim, Bette Seamonds
- RELATION BETWEEN HEMOGLOBIN (HB) AND KIDNEY FUNCTION (EGFR) IN DIABETICS (DM) VS. NONDIABETICS (NDM) WITH NEPHROPATHY
Sreevalli Pariti1, Timothy Poole2, B Adams-Huet1, Robert Toto1 UT Southwestern Medical Center1 and Parkland Hospital2, Dallas,TX
- NEPHROTIC PROTEINURIA IN ADPKD - A CLINICAL CHALLENGE
Prabodh Ranjan, H Magoo, EH Anjum, C Desai, D Baumstein, A Chaudhari, AM Tannenberg, Metropolitan Hospital Center, NewYork Medical College, NY
- TREATMENT PATTERNS IN PATIENTS PROGRESSING THROUGH LATER-STAGE CHRONIC KIDNEY DISEASE (CKD): BASELINE DATA FROM A PROSPECTIVE OBSERVATIONAL REGISTRY
W Shapiro1, C Martinez2, C Charytan3, J Horowitz4, D Tharpe5, J Droge6, X Ling6, V Belozeroff6, W Goodman6, G Block7, S Sprague8. 1Kidney Care Assoc, Brooklyn, NY; 2Renal Physicians of GA, Macon, GA; 3NY Hospital Medical Center Queens, Flushing, NY; 4Horowitz PLC, Fall River, MA; 5Nephrol Assoc, Birmingham, AL; 6Amgen, Thousand Oaks, CA; 7Denver Nephrol, Denver, CO; 8Evanston Northwestern Healthcare, Evanston, IL.
- PREDICTORS OF DISEASE PROGRESSION IN SUBJECTS WITH STAGE 3 OR 4 CKD
David Simon1, Fredrick Finkelstein1, Beth Barber2, Louis Matza3, Rohit Borker2, Karen Malley4 1Metabolism Associates, P.C., New Haven, CT, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3United BioSource, Corp., Bethesda, MD, USA, 4Malley Research Programming, Inc., Rockville, MD, USA
- EVALUATION OF FERUMOXYTOL SAFETY AND EFFICACY IN ALL STAGES OF CHRONIC KIDNEY DISEASE (CKD)
B Spinowitz1, AT Kausz2, J Dioguardi2, C Kovesdy3 1NY Hospital, Queens, NY; 2AMAG Pharmaceuticals, Inc. Cambridge, MA; 3Salem Veteran’s Affairs Medical Center, Salem, VA
- EFFECTS OF VITAMIN D ON ESA REQUIREMENTS IN CKD STAGE 3-4
Stuart Sprague, Yvette Shannon, Nadia Khambati, Paulynn Katsulis, Lumi Stutz, and Louisa Ho; Evanston Northwestern Healthcare, NUFSOM, Evanston, IL
- ERGOCALCIFEROL AND ACTIVE VITAMIN D FOR HYPERPARATHYROIDISM IN CKD
Stuart M. Sprague, Louisa Ho, and Nadia Khambati; Evanston Northwestern Healthcare, NUFSOM, Evanston, IL
- LANTHANUM CARBONATE REDUCES PHOSPHATE BURDEN IN PATIENTS WITH CKD STAGES 3 AND 4: RESULTS FROM A RANDOMIZED MULTICENTER TRIAL
Stuart Sprague1, William Finn2, Hanna Abboud3, Ping Qiu4 on behalf of the SPD405-206 study investigators; 1Evanston Northwestern Healthcare, Northwestern University, Evanston, IL; 2Division of Nephrology & Hypertension, University of North Carolina Kidney Center, Chapel Hill, NC; 3University of Texas Health Science Center at San Antonio, Medicine/ Nephrology, San Antonio, TX; 4Shire Pharmaceuticals, Wayne, PA
- CHARACTERIZING TREATMENT OF STAGE 3 CHRONIC KIDNEY DISEASE (CKD) AMONGST HISPANICS, AFRICAN-AMERICANS (AA), AND CAUCASIANS.
Salman Waheed, Rajeev Rohatgi, Department of Medicine, James J. Peters VA Medical Center, Bronx, N.Y, USA.
- APPARENT DIFFUSION COEFFICIENT EVALUATE THE RECOVERABILITY OF RENAL FUNCTION IN PATIENT WITH UNILATERAL HYDRONEPHROSIS AFTER PERCUTANEOUS NEPHROLITHOTOMY
Baojun Xie, Xiaobin Zhang, Wuhan, P.R China
- RENAL ALLOGRAFT SURVIVAL AMONG PATIENTS WITH LUPUS NEPHRITIS
Muhammad Ashraf, Nagaraju Sarabu, St. Luke’s Hospital, Chesterfield, MO. Daniel C. Brennan, Washington University, St. Louis, MO, USA
- CONVERSION FROM CYCLOSPORINE TO TACROLIMUS BASED IMMUNOSUPPRESSION THERAPY IN RENAL TRANSPLANT RECIPIENTS
Lars Bäckman, Transplant Institute Sahlgrenska University Hospital, Gothenburg, Sweden
- RECURRENT ATYPICAL HEMOLYTIC UREMIC SYNDROME ASSOCIATED WITH FACTOR I MUTATION IN A LIVING RELATED RENAL TRANSPLANT RECIPIENT
Micah R. Chan, Christie P. Thomas, Richard J. Smith, Jose Torrealba, Millie Samaniego, University of Wisconsin Hospitals and Clinics, Madison, WI; University of Iowa Hospitals and Clinics, Iowa City, IA
- DISCONNECT BETWEEN BETA-2 MICROGLOBULIN AND CREATININE AFTER RENAL TRANSPLANT
Mohammed Atiq Dada , Swetha Nataraj, Sharad Sathyan, David Hull, Kory Tray and K. Vinay Ranga
- COMPLICATIONS OF PEDIATRIC LIVE-DONOR KIDNEY TRANSPLANTATION IN DEVELOPING COUNTRY: SINGLE CENTER'S EXPERIENCE FROM EGYPT
Amr A El-Husseini, Mohamed A Sobh; Urology & Nephrology Center, Mansoura University, Egypt
- RECURRENT MEMBRANOUS LUPUS NEPHRITIS IN A RENAL ALLOGRAFT TREATED WITH RITUXIMAB
Jennifer Fillaus, Troy Plumb, Clifford Miles, Gerald Groggel, Marius Florescu, Vinaya Rao; University of Nebraska Medical Center, Omaha NE
- HEART TRANSPLANT ANTI-REJECTION THERAPY DOES NOT PREVENT DE NOVO IMMUNE MECHANISM KIDNEY DISEASE
Jasjot Garcha, Allan B. Schwartz, Nedjema Sustento-Reodica, Howard Eisen, Shelly Hankins - Drexel University College of Medicine, Philadelphia, PA, USA
- A COMPARATIVE STUDY OF STEROID SPARING IMMUNOSUPRESSIVE REGIMEN WITH STEROID INCLUSIVE REGIMEN IN RENAL TRANSPLANT PATIENTS
Lekha K. George, Liliana Soltero, Horacio E. Adrogue, Baylor College of Medicine, Houston, Texas, USA
- DE NOVO MINIMAL CHANGE DISEASE (MCD) FOLLOWING KIDNEY TRANSPLANTATION
Nimrta Ghuman, Vedavati Patel, John de Palma, Arvind Datla, Swetha Nataraj, K. Vinay Ranga. Medicine / Transplantation, Hartford Hospital / UCHC, Farmington, Connecticut
- DIAGNOSTIC IMAGING CLUES AND MANAGEMENT OF SUDDEN BLINDNESS AFTER RENAL TRANSPLANT
K.Janga, K. Sharma, D.Glicklich, S.Greenberg, VA.Tellis, SM.Greenstein, RS.Schechner; Montefiore Medical Center, Bronx NY, USA
- NEED FOR DIAGNOSTIC CRITERIA FOR ANTIBODY MEDIATED REJECTION (AMR) IN PANCREAS AFTER KIDNEY TRANSPLANTATION
Subramanian Kannan, Renu Bansal, Swetha Nataraj, Sharad Sathyan, Andrew Ricci, K. Vinay Ranga. Medicine / Pathology / Transplant, Hartford Hospital / UCHC, Farmington, CT
- DE NOVO CELLULAR FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) ASSOCIATED WITH SIROLIMUS: A CASE REPORT
Rakesh Lattupalli, El Ghoroury, Darla Granger, Hong Qu. Division of Nephrology, St John Hospital Medical Center, Detroit, MI
- INFECTION PATTERNS IN HIV POSITIVE AND HIV NEGATIVE RENAL TRANSPLTAN PATIENTS
Lina Mackelaite, Nauman Shahid, Iram Mahmood, Gary Xiao, Ziauddin Ahmed, Karthik Ranganna
- IS ASYMPTOMATIC PYURIA A RISK FACTOR OF INFECTIUOUS COMPLICATIONS AFTER SURVEILLANCE RENAL TRANSPLANT BIOPSY?
Lina Mackalaite, Quingdi Geng, Karthik Ranganna, Anil Kumar, Ziauddin Ahmed
- DE NOVO RENAL CELL CARCINOMA AFTER KIDNEY TRANSPLANTATION: A CASE REPORT
Radhika Medipalli and Ehab R Saad; Medical College of Wisconsin Milwaukee, Wisconsin, USA
- PERFORMANCE OF CURRENT EQUATIONS FOR ESTIMATION OF GFR IN DIFFERENT STAGES OF CKD AMONG RENAL TRANSPLANT RECIPIENTS
Osama El Minshawy, MD1,2 and Antonio Guasch, MD1; 1Renal Division, Dept. of Medicine, Emory University, USA 2on Sabbatical leave from El Minia University School of Medicine, El Minia, Egypt
- USE OF ERYTHROCYTE STIMULATING AGENT DURING RENAL TRANSPLANTATION
Niyoti Modi, Ziauddin Ahmed,Iram Mahmood, Anil Kumar, Karthik Ranganna, Devasmita Chowdhury
- DE NOVO FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) FOLLOWING RENAL TRANSPLANT IN A PATIENT WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Swetha Nataraj, Vinitha Vellanki, Atiq Dada, Fabiola Balarezo, K. Vinay Ranga. Medicine /Pathology / Transplantation, Hartford Hospital / UCHC, Hartford, CT
- OUTCOMES IN RECIPIENTS AND DONORS OF COMMERCIAL KIDNEY TRANSPLANTATION
Imran Sajjad1 and Rahul M. Jindal2. 1Department of medicine University of Wisconsin, 2Department of Surgery Brookdale University Hospital Brooklyn
- CLINICAL IMPROVEMENT IN NEPHROGENIC SYSTEMIC FIBROSIS (NSF) FOLLOWING RENAL TRANSPLANTATION: SHOULD ‘NSF POINTS’ BE CONSIDERED IN ALLOCATION?
Sharad Sathyan , Swetha Nataraj, M. Atiq Dada, K. Vinay Ranga; Medicine / Transplantation, Hartford hospital/UCHC, Farmington, CT
- CO-EXISTING PERITUBULAR CAPILLARY (PTC) BASEMENT MEMBRANE LAMINATION AND PODOCYTE EFFACEMENT ON EM IN KIDNEY TRANSPLANT ON CNI-FREE REGIMEN
Sharad Sathyan, Zeeshan Khawaja, John de Palma, Mathew Brown, Anne Lally, David Hull, K.Vinay Ranga. Medicine / Transplantation, Hartford Hospital / UCHC, Farmington, CT
- PROPHYLAXIS OF GENTAMICIN NEPHROTOXICITY
W. Brian Somerset, Robert Gayner, Joseph Jacobs, Adam Dratch, Robert Pursell, Richard Snyder. Department of Nephrology, St. Luke’s Hospital and Health Network, Bethlehem, PA
- HYPEROXALURIA AFTER BARIATRIC SURGERY IN A POTENTIAL KIDNEY DONOR MAY ACTUALLY PRECLUDE KIDNEY DONATION
Vinitha Vellanki, M. Atiq Dada, Sharad Satyan, Vikram Beemidi, K. Vinay Ranga. Medicine / Transplantation, Hartford Hospital UCHC, Farmington, CT
- SUCCESSFUL LIVING KIDNEY DONATION AFTER ABLATION OF ACCESSORY CONDUCTING PATHWAY IN THE DONOR
Faisal Zaeem, Arvind Datla, Nitesh Sood, Jeffrey Kluger, Ravi Yarlagadda, David Hull, K. Vinay Ranga. Medicine / Transplantation., Hartford Hospital/ UCHC, Farmington, Connecticut
- EXPANDED PLASMA VOLUME IN WALDENSTROM’S MACROGLOBULINEMIA AS EVIDENCED BY IGM REDUCTION RATIOS DURING THERAPEUTIC PLASMA EXCHANGE (TPE)
Fabio Aglieco, Renu Bansal, Andre A. Kaplan; University of Connecticut Health Center, Farmington, CT
- AWARENESS AND KNOWLEDGE OF CHRONIC KIDNEY DISEASE CLINICAL PRACTICE GUIDELINES AMONG INTERNAL MEDICINE RESIDENTS. A NATIONAL SURVEY
Varun Agrawal, William Beaumont Hospital, Royal Oak MI, USA;
Michael A. Barnes, William Beaumont Hospital, Royal Oak MI, USA; Amit K. Ghosh, Mayo Clinic, Rochester MN, USA
- ESTIMATION OF GFR BY MDRD FORMULA AND ITS CORRELATION TO COCKCROFT-GAULT EQUATINO IN FIVE STATES OF CHRONIC KIDNEY DISEASE
Ali A, Rais Z, Asif N, Adnan F, Kashif W, Merchant D, Yaqub S. Aga Khan University Hospital, Dept of Medicine, Nephrology Section, and Liaquat National Hospital, Karachi Pakistan
- ALTERNATING ANCA SPECIFICITY FROM cANCA TO pANCA IN A STAGE 5 CKD PATIENT WITH PALPABLE PURPURA
Ehteshamul h Anjum, Hena Kausar, Saint Augustine, Florida, USA
- APPLYING AN EXPANDED SET OF COGNITIVE DESIGN PRINCIPLES TO FORMATTING THE NKF KIDNEY EARLY EVALUATINO PROGRAM LONGITUDINAL SURVEY (KEEP-LS)
José Luis Calderón1,2, Erik Fleming2, Monica Gannon3, Shu-Cheng Chen4, Joseph A. Vassaloti3, Keith C. Norris2,5. 1College of Pharmacy, Health Professions Division, Nova Southeastern University, Fort Lauderdale, Florida, 2Charles R. Drew University of Medicine and Science, Los Angeles, California, 3National Kidney Foundation, New York, New York, 4KEEP Data coordinating Center, Minneapolis, Minnesota, 5David Geffen School of Medicine, University of California, Los Angeles (UCLA)
- NEPHROGENIC FIBROSING DERMOPATHY (NFD) IN A PATIENT WITH ACUTE KIDNEY INJURY (AKI)
Ashish Dhungel, Rakesh Lattupalli, Mohammed El Ghoroury, Robert Provenzano, Joel Topf, Division of Nephrology, St John Hospital and Medical Center, MI
- DIFFERENTIAL EFFECTS OF CALCITRIOL AND PARICALCITOL ON VASCULAR CALCIFICATION IN HIGH PHOSPHATE-FED, UREMIC MICE
Mohga El-Abbadi, Bryan Bartley, Cameron Gaskill, Carly Ingalls, and Cecilia M. Giachelli, University of Washington, Seattle, WA, USA
- RENAL CELL CARCINOMA IN A 22 YEAR OLD PATIENT WITH SINUS HISTIOCYTOSIS
Ziad El-Zoghby; Nelson Leung; Department of Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN
- TREATMENT OF SARCOID GRANULOMATOUS INTERSTITIAL NEPHRITIS WITH ADALIMUMAB
Roopali Gupta, Jack Moore Jr, Lisa Beaudet, Tulsi K Mehta; Deparments of Nephrology and Pathology,Washington Hospital Center, Washington DC, USA
- ULTRASOUND VERSUS CT-SCAN GUIDED KIDNEY BIOPSY
Amit Joshi, Suresh Pasya, Gaurav Jain, Peter Hart. Section of Nephrology, John H. Stroger Hospital of Cook County, Chicago, Illinois, 60612, USA
- COMPARISON OF MOTIVATIONAL INTERVIEWING TO STANDARD COUNSELING ON PHOSPHORUS LEVELS IN HEMODIALYSIS SUBJECTS
Nina Kolbe DaVita Union Plaza, Washington, DC, USA; Mary Burgess DaVita Reston, Woodbridge, VA USA
- APPARENT DISPARITY IN TESTING OF PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD), PLUS DIABETES AND/OR HYPERTENSION AND IMPACT OF GENDER
Eileen Koski1, Xiaohua Huang2, Marsha Green1, Harvey Kaufman3, Herman Hurwitz4, Richard Furlanetto5, and Joseph Vassalotti6. 1-5Quest Diagnostics Incorporated: 1Lyndhurst NJ, 2West Norriton PA, 3Madison NJ, 4Philadelpia PA, 5Chantilly VA, 6National Kidney Foundation and Mount Sinai School of Medicine New York NY
- DRUG UTILIZATION AND COST CONSIDERATIONS OF PREDIALYSIS CHRONIC KIDNEY DISEASE PATIENTS RECEIVING ERYTHROPOIETIC STIMULATING AGENTS THROUGH PHARMACY BENEFITS
François Laliberté1, Patrick Lefebvre1, Francis Vekeman1, Janice Lopez2, R. Scott McKenzie2, Brahim Bookhart2 1Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC, Bridgewater, NJ, USA
- NEPHROGENIC FIBROSING DERMOPATHY (NFD): CASE SERIES OF 3 PATIENTS IN A SINGLE CENTER
Rakesh Lattupalli, Ashish Dhungel, Keith Bellovich, Robert Provenzano, Joel Topf. Division of Nephrology, St John Hospital and Medical Center, MI
- ASSESSMENT OF DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIETIC STIMULATING AGENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Patrick Lefebvre1, François Laliberté1, Marie-Héléne Lafeuille1, Brahim Bookhart2, R. Scott McKenzie2, Mitra Corral2, Catherine Piech2
1Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC, Bridgewater, NJ, USA
- UTILIZATION OF ERYTHROPOEISIS STIMULATING PROTEINS IN HOSPITALIZED PATIENTS
Antonio Ligon, Yin Ping Liew, Sam Butler, Julie Barnes, Martin Schreiber
Cleveland Clinic, Cleveland, Ohio, USA
- CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASE IN VOLUNTEER AND RANDOMLY SELECTED POPULATIONS: KEEP AND NHANES
Peter A. McCullough1, Suying Li2, Claudine T. Jurkovitz3, Lesley A. Stevens4, Changchun Wang2, Allan J. Collins2, Shu-Cheng Chen2, Keith C. Norris5, Samy McFarlane6, Bruce Johnson7, Michael G. Shlipak8, Chamberlain I. Obialo9, Wendy W. Brown10, Joseph A. Vassalotti11, Adam T. Whaley-Connell12, on Behalf of the KEEP Investigators. 1-10Attributions for the authors will be provided as a poster.
- RACIAL AND GENDER DIFFERENCES IN PREVALENCE AND PREDICTORS OF ANEMIA OF CHRONIC KIDNEY DISEASE: KEEP AND NHANES 1999-2004
Samy I. McFarlane1, Shu-Cheng Chen2, Adam Whaley-Connell3, James Sowers3, Joseph A. Vassalotti4, Moro O. Salifu1, Suying Li2, Changchun Wang2, George Bakris5, Peter McCullough6, Allan J. Collins2, and Keith Norris7, on behalf of the KEEP Investigators.
1-7Attributions for the authors will be provided as a poster.
- CALCIPHYLAXIS FROM NON-UREMIC ETIOLOGIES: A SYSTEMATIC REVIEW
Sagar U Nigwekar, John K Hix; Rochester General Hospital, Rochester, NY, USA
- SARCOIDOSIS “UNMASKED”
Sagar U Nigwekar, Bishoy Faltas, John K Hix; Rochester General Hospital, Rochester, NY, USA
- INTER-RELATIONS BETWEEN B-TYPE NATRIURETIC PEPTIDES & VIT D IN PATIENTS ON MAINTENANCE PERITONEAL DIALYSIS & IN WOMEN POST-PARTUM
Enyioma N Obineche*, Hussain Saadi*, Sheela Benedict*, Javed Pathan*, Christopher M Frampton+ and M Gary Nicholls+. *Department of Internal Medicine, Faculty of Medicine & Health Sciences, UAE University, Al Ain, United Arab Emirates and +Department of Medicine & Health Sciences, Christchurch Hospital, Christchurch, New Zealand
- CARDIOVASCULAR EVENTS AND MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS TREATED WITH EPOETIN ALFA OR DARBEPOETIN ALFA
Erdal Sarac, Victor Lossev, Donald J. Misquitta, Ali Dinani, and David Gemmel. Northeastern Ohio Universities College of Medicine, Rootstown, Ohio and St. Elizabeth Health Center, Youngstown, Ohio, USA.
- FEASIBILITY OF INTERNET-BASED DATA COLLECTION WITH PEOPLE WHO HAVE KIDNEY DISEASE
Renee N. Saris-Baglama1, Kimberly Clayton2, Michelle M. Richardson2, Monica Gannon3, Gigi Politoski3, Milena D. Anatchkova1, Diane M. Turner-Bowker1, Lesley A. Stevens2, Dana C. Miskulin2, Wendy Brown3, Sheila Weiner3, John E. Ware1, Klemens B. Meyer2 1QualityMetric Incorporated, Lincoln, RI, USA 2Tufts-New England Medical Center, Boston, MA, USA 3National Kidney Foundation, New York, NY, USA
- STANDARDIZATINO OF SERUM CREATININE AND ESTIMATED GLOMERULAR FILTRATION RATE IN THE NATIONAL KIDNEY FOUNDATION KIDNEY EARLY EVALUATION PROGRAM (KEEP)
Lesley A. Stevens1, Nicholas Stoycheff1. 1Tufts-New England Medical Center, Boston, Massachusetts
- DIFFERENT TOXICITY ON RENAL TISSUE BETWEEN NEW AND OLD ORIGINAL INTRAVENOUS IRON PREPARATIONS IN NORMAL RATS
Toblli Jorge; Cao Gabriel, Oliveri Leda; Angerosa Margarita. Lab. Experimental Medicine. Hospital Alemán. Buenos Aires.
- SURVEY OF DRIVING HABITS AND ASSESSMENT OF RISK IN DIALYSIS PATIENTS
Hemender Vats, Douglas Duffy Marshfield Clinic, Marshfield, Wisconsin, USA
- RENAL NURSES’ PERCEPTION OF DIALYSIS ASSISTANT IN HONG KONG
Flora SY Wong, WK Chan, ALC Cheung, SSK Wong, KH Chan, Alex W. Yu. Renal Unit, Dept. of Medicine, AHML Nethersole Hospital, Hong Kong
- FUNCTIONAL ANALYSIS OF HUMAN MUTATIONS IN NAPI-IIC REVEALS IMPORTANT RESIDUES FOR SURFACE EXPRESSION AND SODIUM-PHOSPHATE CO-TRANSPORT
Clemens Bergwitz1, Graciana Jaureguiberry1, Thomas O Carpenter3, Stuart Forman2, Harald Jüppner1; 1Endocrine Unit and 2Dept. of Anesthesiology, Massachusetts General Hospital, Boston, MA, United States; 3Dept. of Pediatrics and Endocrine Unit, Yale School of Medicine, New Haven, CT, United States
- URINARY MARKERS FOR PROGRESSIVE RENAL FIBROSIS
Bitzer M, Shang H, Lim J, Ju W, Kopp JB, Hostetter TH, Angeletti RH. Albert Einstein College of Medicine, Bronx, NY; Mount Sinai School of Medicine, NY, NY; NIDDK, NIH, Bethesda, MD
- GRANULOGENESIS IN SYMPATHOADRENAL CHROMAFFIN CELLS: CONTRIBUTION OF THE NEUROENDOCRINE SECRETORY PROTEIN SECRETOGRANIN II.
Maïté Courel1, Daniel T. O'Connor1,2, Laurent Taupenot1,2 1Dept of Medicine, University of California at San Diego, La Jolla, CA, 2VASDHS, San Diego, CA, USA
- HD CATHETERS AND INFLAMMATION ARE DETERMINANTS OF ERYTHROPOIETIN (EPO) REQUIREMENTS
Adriana Hung, Edward Siew, Kerri Cavanaugh, Raymond Hakim, Alp Ikizler Vanderbilt University, Nashville, TN; Veterans Administration Tennessee Valley Healthcare System, Nashville, TN
- ARE VASCULAR ACCESS OUTCOMES IN THE FISTULA FIRST ERA AFFECTED BY THE SURGEON?
Timmy Lee1, and Michael Allon2, 1University of Cincinnati, Cincinnati, OH. 2University of Alabama at Birmingham, Birmingham, AL.
- STENT vs. ANGIOPLASTY FOR TREATMENT OF THROMBOSED AV GRAFTS: LONG TERM OUTCOMES.
Ivan D. Maya. UAB, Birmingham, AL. USA
- ESTABLISHING A FRAMEWORK TO INFER GENE REGULATORY NETWORKS FOR KIDNEY DEVELOPMENT
Luis F Menezes1, Klaus Piontek1, Carlo Colantuoni2, Scott Patterson3, Joel Bader3, Gregory G Germino1.; 1: School of Medicine; 2: School of Public Health and 3: Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
- PRIMARY CILIA REGULATE cAMP-DEPENDENT SIGNALING IN KIDNEY CELLS
Akira Suzuki and Peter Igarashi, University of Texas Southwestern Medical Center, Dallas, TX